Unique Fabricating (UFABQ) 10-Q/A 15 Apr 21 2020 Q2 Quarterly report (amended) Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2020	Mar. 29, 2021
Cover [Abstract]
Document Type	10-Q/A
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2020
Document Transition Report	false
Entity File Number	001-37480
Entity Registrant Name	UNIQUE FABRICATING, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-1846791
Entity Address, Address Line One	800 Standard Parkway
Entity Address, City or Town	Auburn Hills
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48326
City Area Code	248
Local Phone Number	853-2333
Title of 12(b) Security	Common Stock, par value $.001 per share
Trading Symbol	UFAB
Security Exchange Name	NYSEAMER
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		9,779,147
Entity Central Index Key	0001617669
Amendment Flag	true
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Amendment Description	On March 31, 2021, the Audit Committee of the Board of Directors of Unique Fabricating, Inc. (the “Company”), after consultation with management and discussions with Deloitte & Touche LLP, the Company’s independent registered public accounting firm, concluded that the Company’s previously issued 2020 quarterly condensed consolidated financial statements for the quarters ended March 31, 2020, June 30, 2020, and September 30, 2020 (collectively, the “Relevant Periods”) should be restated to reflect the impact of certain errors the Company has identified and, accordingly, should no longer be relied upon. This Amendment No. 1 to the Company’s Quarterly Report on Form 10-Q (the “Form 10-Q/A) for the three and six months ended June 30, 2020, which was originally filed with the U.S. Securities and Exchange Commission (“SEC”) on August 13, 2020 (the “Original Form 10-Q”), restates the Company's condensed consolidated financial statements as of and for the three and six months ended June 30, 2020, and amends the related Notes and disclosures thereto.

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 29, 2019
Current assets
Cash and cash equivalents	$ 4,098	$ 650
Accounts receivable, net of reserves of approximately $0.7 million and $0.9 million at June 30, 2020 and December 29, 2019, respectively	15,683	24,701
Inventory, net	14,810	13,047
Prepaid expenses and other current assets:
Prepaid expenses and other	3,574	2,108
Refundable taxes	1,391	1,049
Assets held for sale	0	1,003
Total current assets	39,556	42,558
Property, plant, and equipment, net	22,779	23,415
Goodwill	22,111	22,111
Intangible assets	9,625	11,625
Other assets
Operating leases	10,965	0
Investments, at cost	1,054	1,054
Deposits and other assets	227	226
Deferred tax asset	1,219	679
Total assets	107,536	101,668
Current liabilities:
Accounts payable	7,784	9,324
Current maturities of long-term debt	2,847	2,847
Accrued compensation	1,144	1,225
Other accrued liabilities	4,543	1,979
Total current liabilities	16,318	15,375
Long-term debt, net of current maturities	37,794	33,220
Line of credit	9,874	11,418
Other long-term liabilities:
Deferred tax liability	0	1,324
Other liabilities	10,659	871
Total liabilities	74,645	62,208
Stockholders’ equity:
Common stock, $0.001 par value: 15,000,000 shares authorized and 9,779,147 and 9,779,147 issued and outstanding at June 30, 2020 and December 29, 2019, respectively	10	10
Additional paid-in-capital	46,066	46,011
Accumulated deficit	(13,185)	(6,561)
Total stockholders’ equity	32,891	39,460
Total liabilities and stockholders’ equity	$ 107,536	$ 101,668

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 29, 2019
Statement of Financial Position [Abstract]
Allowance for doubtful accounts receivable	$ 0.7	$ 0.9
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	15,000,000	15,000,000
Common stock, shares issued (in shares)	9,779,147	9,779,147
Common stock, shares outstanding (in shares)	9,779,147	9,779,147

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
Net sales	$ 14,975	$ 38,889	$ 49,636	$ 78,356
Cost of sales	13,134	30,677	42,204	61,844
Gross profit	1,841	8,212	7,432	16,512
Selling, general, and administrative expenses	6,343	7,424	12,227	14,696
Impairment	0	6,760	0	6,760
Restructuring expenses	273	734	1,193	825
Operating loss	(4,775)	(6,706)	(5,988)	(5,769)
Other income (expense):
Other, net	18	25	(6)	43
Interest expense	(623)	(1,332)	(2,289)	(2,432)
Other expense, net	(605)	(1,307)	(2,295)	(2,389)
(Loss) before income tax (benefit)	(5,380)	(8,013)	(8,283)	(8,158)
Income tax (benefit)	(1,058)	(389)	(1,659)	(346)
Net loss	$ (4,322)	$ (7,624)	$ (6,624)	$ (7,812)
Earnings Per Share [Abstract]
Basic (in dollars per share)	$ (0.44)	$ (0.78)	$ (0.68)	$ (0.80)
Diluted (in dollars per share)	(0.44)	(0.78)	(0.68)	(0.80)
Dividends declared per share (in dollars per share)	$ 0	$ 0	$ 0	$ 0.05

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)
Stockholders' equity, beginning balance (in shares) at Dec. 30, 2018	9,779,147
Stockholders' equity, beginning balance at Dec. 30, 2018	$ 48,888	$ 10	$ 45,882	$ 2,997
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(189)			(189)
Stock option expense	33		33
Cash dividends paid	$ (489)			(489)
Stockholders' equity, ending balance (in shares) at Mar. 31, 2019	9,779,147
Stockholders' equity, ending balance at Mar. 31, 2019	$ 48,243	10	45,915	2,319
Stockholders' equity, beginning balance (in shares) at Dec. 30, 2018	9,779,147
Stockholders' equity, beginning balance at Dec. 30, 2018	$ 48,888	10	45,882	2,997
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (7,812)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2019	9,779,147
Stockholders' equity, ending balance at Jun. 30, 2019	$ 40,684	10	45,980	(5,305)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2019	9,779,147
Stockholders' equity, beginning balance at Mar. 31, 2019	$ 48,243	10	45,915	2,319
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,624)			(7,624)
Stock option expense	$ 65		65
Stockholders' equity, ending balance (in shares) at Jun. 30, 2019	9,779,147
Stockholders' equity, ending balance at Jun. 30, 2019	$ 40,684	10	45,980	(5,305)
Stockholders' equity, beginning balance (in shares) at Dec. 29, 2019	9,779,147
Stockholders' equity, beginning balance at Dec. 29, 2019	$ 39,460	10	46,011	(6,561)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,302)
Stock option expense	$ 23		23
Stockholders' equity, ending balance (in shares) at Mar. 31, 2020	9,779,147
Stockholders' equity, ending balance at Mar. 31, 2020	$ 37,181	10	46,034	(8,863)
Stockholders' equity, beginning balance (in shares) at Dec. 29, 2019	9,779,147
Stockholders' equity, beginning balance at Dec. 29, 2019	$ 39,460	10	46,011	(6,561)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (6,624)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2020	9,779,147
Stockholders' equity, ending balance at Jun. 30, 2020	$ 32,891	10	46,066	(13,185)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2020	9,779,147
Stockholders' equity, beginning balance at Mar. 31, 2020	$ 37,181	10	46,034	(8,863)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(4,322)
Stock option expense	$ 32		32
Stockholders' equity, ending balance (in shares) at Jun. 30, 2020	9,779,147
Stockholders' equity, ending balance at Jun. 30, 2020	$ 32,891	$ 10	$ 46,066	$ (13,185)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash Flows from Operating Activities:
Net loss	$ (6,624)	$ (7,812)
Adjustments to reconcile net loss to net cash provided by operating activities:
Impairment of goodwill	0	6,760
Depreciation and amortization	3,458	3,404
Amortization of debt issuance costs	74	89
Loss on sale of assets	108	5
Bad debt adjustment	554	122
Loss on derivative instrument	598	665
Stock option expense	55	98
Deferred income taxes	(1,864)	(728)
Changes in operating assets and liabilities that provided (used) cash:
Accounts receivable	8,464	2,576
Inventory	(1,694)	1,064
Prepaid expenses and other assets	(1,809)	(97)
Accounts payable	(1,228)	(107)
Accrued and other liabilities	(601)	(956)
Other, net	1,202	0
Net cash provided by operating activities	693	5,084
Cash Flows from Investing Activities:
Capital expenditures	(760)	(1,880)
Proceeds from sale of property, plant and equipment	884	41
Net cash provided by (used in) investing activities	124	(1,839)
Cash Flows from Financing Activities:
Net change in bank overdraft	(311)	557
Payments on term loans	(1,474)	(2,638)
Payments on revolving credit facilities	(12,310)	(15,189)
Distribution of cash dividends	0	(489)
Net cash provided by (used in) financing activities	2,631	(3,600)
Cash and cash equivalents:
Net increase (decrease) in cash and cash equivalents	3,448	(355)
Cash and cash equivalents at beginning of period	650	1,410
Cash and cash equivalents at end of period	4,098	1,055
Supplemental disclosure of cash flow information:
Cash paid for interest	2,219	1,909
Cash paid for Income taxes	209	292
Line of credit for capital expenditures
Cash Flows from Financing Activities:
Proceeds from lines of credit	0	1,300
Revolving credit facility
Cash Flows from Financing Activities:
Proceeds from lines of credit	10,727	12,858
Proceeds from PPP loan	$ 5,999	$ 0

Nature of Business and Basis of

Nature of Business and Basis of Presentation	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Nature of Business and Basis of Presentation	Nature of Business and Basis of Presentation Nature of Business Unique Fabricating, Inc. (the “Company”) engineers and manufactures components for customers in the transportation, appliance, medical, and consumer markets. The Company’s solutions are comprised of multi-material foam, rubber, and plastic components and utilized in noise, vibration and harshness (“NVH”) management, acoustical management, water and air sealing, decorative and other functional applications. Unique leverages proprietary manufacturing processes, including die cutting, thermoforming, compression molding, fusion molding, and reaction injection molding to manufacture a wide range of products including air management products, heating ventilating and air conditioning (“HVAC”), seals, fender stuffers, air ducts, acoustical insulation, door water shields, gas tank pads, light gaskets, topper pads, mirror gaskets, glove box liners personal protection equipment, and packaging. The Company operates as one reportable segment and is headquartered in Auburn Hills, Michigan. Basis of Presentation The Company’s condensed consolidated financial statements have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principals have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements contain all material adjustments (consisting only of normal recurring adjustments) necessary to present fairly the consolidated financial position of the Company, its results of operations, and its cash flows. The interim results for the periods presented may not be indicative of the Company's actual annual results. The Company’s Statement of Cash Flows, presented above, has been recast to show the gross movements of payments on and proceeds from our revolving credit facility. The Company’s management believes this presentation provides a more transparent view of the activity, as such prior periods have been recast for comparability. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K/A for the year ended December 29, 2019. Change in Quarter and Year-End Historically, the Company’s quarterly periods ended on the Sunday closest to the end of the calendar quarterly period. For 2019, the quarters and year to date period, which were 13 weeks, respectively, ended on March 31, June 30, September 29, and December 29, 2019. On March 13, 2020, the Company’s board of directors approved changing our quarterly periods to match calendar quarterly periods. The Company expects the impact of this change on our 2020 result of operations to be immaterial. All year, quarter, and three month references prior to 2020 relate to the Company’s fiscal year and fiscal quarters, unless otherwise stated. For ease of presentation, three and six months ended is used throughout this Quarterly Report on Form 10-Q to represent both the current year calendar quarterly periods and the prior year fiscal year periods. Concentration Risks The Company is exposed to significant concentration risks as follows: Customer and Credit — During the three and six months ended June 30, 2020 and three and six months ended June 30, 2019, the Company’s net sales were derived from customers principally engaged in the North American automotive industry. The following table presents the Company's sales directly and indirectly to General Motors Company (GM), Fiat Chrysler Automobiles (FCA), and Ford Motor Company (Ford) as a percentage of total net sales: Three Months Ended June 30, 2020 Three Months Ended June 30, 2019 Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 General Motors Company 16 % 17 % 16 % 18 % Fiat Chrysler Automobiles 11 % 16 % 15 % 15 % Ford Motor Company 12 % 12 % 14 % 11 % No customer represented more than 10% of direct Company sales for the three and six months ended June 30, 2020. GM accounted for 7% of direct Company sales for the three and six months ended June 30, 2020. Labor Markets — At June 30, 2020, of the Company’s hourly plant employees working in the United States manufacturing facilities, 38% were covered under a collective bargaining agreement which expires in August 2022 while another 6% were covered under a separate collective bargaining agreement that expires in February 2023. International Operations — The Company manufactures and sells products outside of the United States primarily in Mexico and Canada. Foreign operations are subject to various political, economic and other risks and uncertainties inherent in foreign countries. Among other risks, the Company’s operations may be subject to the risks of: restrictions on transfers of funds; export duties, quotas, and embargoes; domestic and international customs and tariffs; changing taxation policies; foreign exchange restrictions; political conditions; and governmental regulations. The following table presents the percentage of the Company's total production in Mexico, Canada, and other foreign markets: Three Months Ended June 30, 2020 Three Months Ended June 30, 2019 Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 Mexico 20 % 19 % 22 % 19 % Canada 12 % 8 % 9 % 7 % Other — % 1 % — % — % The following table presents the percentage of the Company's total net sales represented by net sales from customers located in Mexico, Canada, and other foreign countries: Three Months Ended June 30, 2020 Three Months Ended June 30, 2019 Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 Mexico 17 % 17 % 21 % 18 % Canada 9 % 10 % 8 % 10 % Other — % 1 % — % 1 %

New Accounting Pronouncements

New Accounting Pronouncements	6 Months Ended
	Jun. 30, 2020
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses,” which introduced new guidance for an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Instruments in scope include loans, held-to-maturity debt securities, and net investments in leases as well as reinsurance and trade receivables. In November 2018, the FASB issued ASU 2018-19, which clarifies that operating lease receivables are outside the scope of the new standard. In November 2019, the FASB issued ASU 2019-10, which established the effective date of the new standard for smaller reporting companies as fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact, if any the adoption of the new credit losses model will have on its financial statements. In February 2016, the FASB issued ASU 2016-2, Leases (Topic 842). This update requires lessees to recognize, on the balance sheet, assets and liabilities for the rights and obligations created by leases of greater than twelve months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. We have identified our existing lease contracts and calculated the right of use assets, which are reflected in Other Assets on the Condensed Consolidated Balance Sheets, and lease liabilities, which are reflected in the Other Accrued Liabilities on the Condensed Consolidated Balance Sheets. This guidance was effective for the Company as of January 1, 2020. Adoption of the new standard resulted in the recording of right-of-use assets and liabilities of $12.1 million and $12.8 million as of January 1, 2020. The FASB has issued further ASUs related to the standard providing an optional transition method allowing entities to not recast comparative periods. The Company elected the practical expedients upon transition that retained the lease classification and initial direct costs for any leases that exist prior to adoption of the standard. The Company has approximately $11.9 million of non-cancelable future rental obligations as of June 30, 2020, as shown in Note 11.

Revenues

Revenues	6 Months Ended
	Jun. 30, 2020
Revenue from Contract with Customer [Abstract]
Revenues	Revenues The following table presents the Company's net sales disaggregated by major sales channel for the three and six months ended June 30, 2020 and 2019 (in thousands): Three Months Ended June 30, 2020 Three Months Ended June 30, 2019 Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 Net Sales Transportation $ 11,290 $ 33,517 $ 42,986 $ 67,532 Appliance 2,132 3,504 4,912 7,258 Other 1,553 1,868 1,738 3,566 Total $ 14,975 $ 38,889 $ 49,636 $ 78,356 General Recognition Policy Revenue is recognized by the Company once all performance obligations under the terms of a contract with the Company's customers are satisfied. Generally this occurs with the transfer of control to a customer of its transportation, appliance, and other products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring its products. The Company’s payment terms vary by the type and location of its customers and the products offered. The term between invoicing and when payment is due is not significant. In general for sales arrangements, the Company deems control to transfer at a single point in time and recognizes revenue when it ships products from its manufacturing facilities to its customers. Once a product has shipped, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to transfer upon shipment because the Company has a present right to payment at that time, the customer has legal title to the asset, and the customer has significant risks and rewards of ownership of the asset. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. Contract Balances

Inventory

Inventory	6 Months Ended
	Jun. 30, 2020
Inventory Disclosure [Abstract]
Inventory	Inventory Inventories consist of the following (in thousands): June 30, December 29, Raw materials $ 9,455 $ 7,963 Work in progress 718 129 Finished goods 4,637 4,955 Total inventory $ 14,810 $ 13,047 The Company periodically evaluates inventory for obsolescence, excess quantities, slow moving goods and other impairments of value and establishes reserves for any identified impairments. The allowance for obsolete inventory was $0.9 million and $1.0 million at June 30, 2020 and December 29, 2019, respectively. Included in inventory are assets located in Mexico with a carrying amount of $4.1 million at June 30, 2020 and $3.6 million at December 29, 2019, and assets located in Canada with a carrying amount of $1.1 million at June 30, 2020 and $1.0 million at December 29, 2019.

Property, Plant, and Equipment,

Property, Plant, and Equipment, Net	6 Months Ended
	Jun. 30, 2020
Property, Plant and Equipment [Abstract]
Property, Plant, and Equipment	Property, Plant, and Equipment, Net Property, plant, and equipment, net consists of the following (in thousands): June 30, December 29, Depreciable Land $ 1,663 $ 1,663 Buildings 5,798 5,934 23 – 40 Shop equipment 23,037 22,982 7 – 10 Leasehold improvements 1,248 1,234 3 – 10 Office equipment 1,829 1,866 3 – 7 Mobile equipment 153 190 3 Construction in progress 2,302 1,543 Total cost 36,030 35,412 Less: Accumulated depreciation 13,250 11,997 Net property, plant, and equipment, net $ 22,779 $ 23,415 Depreciation expense was $0.7 million and $1.4 million for the three and six months ended June 30, 2020, respectively, and $0.7 million and $1.4 million for the three and six months ended June 30, 2019 respectively. Included in property, plant, and equipment are assets located in Mexico with a carrying amount of $4.0 million and $4.1 million at June 30, 2020 and December 29, 2019, respectively, and assets located in Canada with a carrying amount of $0.6 million and $0.6 million at June 30, 2020 and December 29, 2019, respectively.

Long-term Debt

Long-term Debt	6 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Long-term Debt	Long-term Debt Credit Agreement On April 29, 2016, Unique Fabricating NA, Inc. (the “US Borrower”) and Unique-Intasco Canada, Inc. (the “CA Borrower”) and Citizens Bank, National Association (“Citizens”), acting as lender and Administrative Agent, and other lenders, entered into a credit agreement (the “Credit Agreement”) providing for borrowings of up to the aggregate principal amount of $62.0 million. The Credit Agreement was a senior secured credit facility and consisted of a revolving line of credit of up to $30.0 million (the “Revolver”) to the US Borrower, a $17.0 million principal amount term loan (the “US Term Loan”) to the US Borrower, and a $15.0 million principal amount term loan (the “CA Term Loan”) to the CA Borrower. At Closing, the US Term Loan and the CA Term Loan were fully funded and the US Borrower borrowed approximately $22.9 million under the Revolver. On August 18, 2017, the US Borrower and the CA Borrower entered into the Second Amendment (the “Amendment”) to the Credit Agreement, with Citizens, acting as Administrative Agent, and other lenders. The Amendment converted $4.0 million of outstanding borrowings under the Revolver into an additional $4.0 million term loan to the US Borrower (the “US Term Loan II”). The conversion of a portion of the outstanding borrowings under the Revolver did not reduce the aggregate amount available to be borrowed under it. On August 8, 2018, the US Borrower and the CA Borrower entered into the Fourth Amendment (the “Fourth Amendment”) to the Credit Agreement, with Citizens, acting as Administrative Agent, and other lenders. The Fourth Amendment required the Company to use the net proceeds from the sale of the Ft. Smith, Arkansas building to reduce the outstanding borrowings under the Revolver. The application of the net proceeds did not permanently reduce the amounts that could be borrowed under the Revolver. The Fourth Amendment also eased, for the fiscal quarter ended September 30, 2018, the financial covenant ratio which determined the Company's ability to pay dividends. On September 20, 2018, the US Borrower and the CA Borrower entered into the Fifth Amendment (the “Fifth Amendment”) to the Credit Agreement, with Citizens, acting as Administrative Agent, and other lenders. The Fifth Amendment temporarily increased the maximum amount that could be borrowed under the Revolver to $32.5 million from its then maximum of $30.0 million. This increase implemented by the Fifth Amendment was effective until October 31, 2018, at which point the maximum amount that could be borrowed under the Revolver reverted back to $30.0 million and was replaced by the Amended and Restated Credit Agreement described below. Amended and Restated Credit Agreement On November 8, 2018, the US Borrower and the CA Borrower entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”), which amended and restated the existing Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders. The Amended and Restated Credit Agreement which is a five two The Revolver, New US Term Loan, and CA Term Loan all mature on November 7, 2023 and bear interest at the Company's election of either (i) the greater of the Prime Rate or the Federal Funds Effective Rate (the “Base Rate”) or (ii) the LIBOR rate, plus an applicable margin ranging from 1.75% to 3.25% per annum in the case of the Base Rate and 2.75% to 4.25% per annum in the case of the LIBOR rate, in each case, based on senior leverage ratio thresholds, measured quarterly, as increased by the Waiver and Fourth Amendment to the Amended and Restated Credit Agreement which is further described below. The fair value of debt at June 30, 2020 under the Revolver, New US Term Loan and CA Term Loan approximates book value based on the variable terms. In addition, the Amended and Restated Credit Agreement allows for increases in the principal amount of the Revolver and the New US and CA Term Loans not to exceed a $10.0 million principal amount, in the aggregate, provided that before and after giving effect to the proposed increase (and any transactions to be consummated using proceeds of the increase), the total leverage and debt service coverage ratios do not exceed specified amounts. The Amended and Restated Credit Agreement also provides for the issuance of letters of credit with a face amount of up to a $2.0 million, in the aggregate, provided that any letter of credit that is issued will reduce availability under the Revolver. As of June 30, 2020, $10.1 million was outstanding under the Revolver. This amount is gross of debt issuance costs which are further described in the next section. The Revolver had an effective interest rate of 5.00% percent per annum at June 30, 2020, and is secured by substantially all of the Company’s assets. At June 30, 2020, the maximum additional available borrowings under the Revolver was $13.5 million which includes a reduction for a $0.1 million letter of credit issued for the benefit of the landlord of one of the Company’s leased facilities. The maximum amount available was further subject to borrowing base restrictions, resulting in a net availability of $0.7 million. Long term debt consists of the following (in thousands): June 30, December 29, U.S. Small Business Administration Paycheck Protection Program loan (PPP Note), payable in equal monthly installments on the first day after the deferment period. The PPP Note is unsecured and bears interest at 1% per annum. The PPP Note may be forgiven subject to the terms of the Paycheck Protection Program. $ 5,999 $ — New US Term Loan, payable to lenders in quarterly installments of $0.3 million through September 30, 2020, $0.6 million through September 30, 2021, and $0.8 million through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5% per annum at June 30, 2020. At June 30, 2020, the balance of the New US Term Loan is presented net of a debt discount of $0.3 million from costs paid to or on behalf of the lenders. 23,743 24,383 CA Term Loan, payable to lenders in quarterly installments of $0.4 million through November 7, 2023, with a lump sum due at maturity. The effective interest rate was 5% per annum at June 30, 2020. At June 30, 2020, the balance of the CA Term Loan is presented net of a debt discount of $0.1 million from costs paid to or on behalf of the lenders. 9,648 10,384 Capital expenditure line payable to lenders in quarterly installments of 7.5% per annum of the outstanding principal balance commencing December 31, 2019 through September 30, 2020, 10% per annum through September 30, 2021, and 12.5% per annum through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5% per annum at June 30, 2020. 1,251 1,300 Total debt excluding Revolver 40,641 36,067 Less current maturities 2,847 2,847 Long-term debt – Less current maturities $ 37,794 $ 33,220 Debt Issuance Costs Debt issuance costs represent legal, consulting, and other financial costs associated with debt financing and are reported netted against the related debt instrument. Amounts paid to or on behalf of lenders are presented as a debt discount and are also shown as a reduction of the associated debt instrument. Debt issuance costs on term debt are amortized using the straight line basis over the term of the related debt (which is immaterially different from the required effective interest method) while those related to revolving debt are amortized using a straight line basis over the term of the related debt. At June 30, 2020 and December 29, 2019, debt issuance costs were $0.3 million and $0.3 million, respectively, while amounts paid to or on behalf of lenders presented as debt discounts were $0.3 million and $0.4 million, respectively. On November 8, 2018, the Company amended its Credit Agreement, to increase the Company's term loan debt. The Company reviewed this amendment for extinguishment accounting and concluded that there were no remaining debt issuance costs not amortized on the revolving debt facility qualified for extinguishment accounting and recognized a loss on extinguishment immediately. The remaining unamortized debt issuance costs not extinguished on the old revolving debt facility and all of the of remaining unamortized debt issuance costs on the term loans did not meet extinguishment accounting and therefore were carried forward to the new revolving debt facility and term loans. Amortization expense of both debt issuance costs and debt discounts has been recognized as a component of interest expense in the amounts of $0.04 million and $0.1 million for the three and six months ended June 30, 2020, respectively, and $0.04 million and $0.1 million for the three and six months ended June 30, 2019, respectively. Covenant Compliance The Amended and Restated Credit Agreement contains customary negative covenants and requires that the Company comply with various financial covenants, including a total leverage ratio and debt service coverage ratio, as defined in the Amended and Restated Credit Agreement. As of June 30, 2020, the Company was in compliance with these financial covenants. Additionally, the New US Term Loan and CA Term Loan each contains a clause, effective December 30, 2018, that requires an excess cash flow payment to be made to the lenders to reduce the New US Term Loan and CA Term Loan if the Company’s cash flow exceeds certain thresholds as defined by the Amended and Restated Credit Agreement. No payments were required to be made in the three and six months ended June 30, 2020. As of March 31, 2019, the Company was not in compliance with the total leverage ratio financial covenant. As a result of this non-compliance, on May 7, 2019, the US Borrower and the CA Borrower entered into the Waiver and First Amendment (the “First Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders. The First Amendment temporarily waived the default on the March 31, 2019 covenant violation until the earlier of June 15, 2019 and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as necessary taking into account the Borrowers current and future financial condition. As a result of this waiver, the lenders did not accelerate the maturity of the debt. On June 14, 2019, the Company entered into the Waiver and Second Amendment (the “Second Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders. The Second Amendment revised the waiver period as defined with respect to the March 31, 2019 covenant violation and resulting default until the earlier of June 30, 2019 (which was June 15, 2019 under the First Amendment to the Amended and Restated Credit Agreement) and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as necessary taking into account the Borrowers current and future financial condition. On June 28, 2019, the Company entered into the Waiver and Third Amendment (the “Third Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders. The Third Amendment revised the waiver period as defined with respect to the March 31, 2019 covenant violation and resulting default until the earlier of July 22, 2019 (which was June 30, 2019 under the Second Amendment to the Amended and Restated Credit Agreement) and the execution and delivery of a further amendment revising the calculation of the total leverage ratio and such other financial covenants as necessary taking into account the Borrowers current and future financial condition. On July 16, 2019, the Company entered into the Waiver and Fourth Amendment (the “Fourth Amendment”) to the Amended and Restated Credit Agreement, with Citizens, acting as Administrative Agent, and the other lenders. The Fourth Amendment provided a permanent waiver by the Lenders and Agent with respect to the Borrower's non-compliance with the total leverage ratio financial covenant, as defined as of March 31, 2019. The Fourth Amendment also revised the definition of consolidated EBITDA and certain financial covenants, including the maximum total leverage ratio and the minimum debt service coverage ratio, as well as adding the requirement that the Company maintain minimum liquidity and minimum unadjusted consolidated EBITDA, each as defined. The Fourth Amendment permits distributions as long as the Borrower is in compliance with specified conditions including that the Borrower's liquidity, as defined, is not less than $5 million after giving effect to the distribution, total leverage ratio is not more than 2.00 to 1.00, post distribution, debt service coverage ratio ("DSCR"), as defined, is not greater than 1.10 to 1.00, and Borrower is in compliance with financial covenants, before and after giving effect to the distributions. On August 7, 2019, the Company entered into the Fifth Amendment to the Credit Agreement and Loan Documents (the “Fifth Amendment”). The Fifth Amendment amended the definition of unadjusted consolidated EBITDA to include consolidated net income plus the sum of interest expense, tax expense, depreciation and amortization expense, and non-cash impairment charges of goodwill. The Company is compliant with the covenants set forth in the Fifth Amendment as of June 30, 2020. On April 3, 2020, the Company entered into the Sixth Amendment to the Credit Agreement and Loan Documents (the “Sixth Amendment”). The Sixth Amendment, amended the definition of consolidated EBITDA to include, as an addition to consolidated net income, an amount equal to $0.6 million resulting from a non-cash inventory write-off taken during the third fiscal quarter in fiscal 2019, amended the definition of “fiscal year” to reflect that we changed our fiscal year to end on December 31, commencing with the 2020 fiscal year, eliminated the requirement for a monthly Covenant Compliance Report and provided for payment of the Capex Loan principal installment that was due December 31, 2019, but was not paid due to an internal system miscalculation by the Agent. As of March 31, 2020, the Company was in compliance with its financial covenants. However, due to the impact of the COVID-19 pandemic on the Company and the global automotive industry, the Company anticipated that it was likely that the Bank EBITDA for the twelve months ended June 30, 2020 was likely to result in the Company not being in compliance with its financial covenants. In response to the anticipated impact of COVID-19, on April 23, 2020, the US Borrower and the CA Borrower (together the “Borrowers”) entered into the Seventh Amendment (the “Seventh Amendment”) to the Credit Agreement and Loan Documents. The Seventh Amendment, among other things, (i) permits additional indebtedness in the form of unsecured loans authorized pursuant to and in compliance with the CARES Act under the Paycheck Protection Program of the U.S. Small Business Administration, in an aggregate amount not to exceed $6.0 million; (ii) defers the June 30, 2020 principal payments on the US Term Loan, CA Term Loan, and CAPEX Loan, with the deferred principal amounts payable at the existing maturity dates; (iii) waives the requirement to test Maximum Total Leverage Ratio, Minimum Debt Service Coverage Ratio and Minimum Unadjusted Consolidated EBITDA for the fiscal quarter ending June 30, 2020; (iv) allows the release of the lien on the Evansville, Indiana property and for the net cash proceeds from its sale to be applied against any outstanding balance on the Revolver, which will not permanently reduce the Revolving Credit Aggregate Commitment; (v) adds a weekly requirement for the Borrowers to deliver a 13-week cash flow forecast until September 30, 2020; and (vi) adds a 1.0% LIBOR Floor and 2.0% Base Rate Floor. On August 7, 2020, the Company entered into the Eighth Amendment (the “Eighth Amendment”) to the Credit Agreement and Loan Documents, as amended. The Eighth Amendment to the Credit Agreement and Loan Documents, among other things, amended the definition of Consolidated EBITDA and made changes to the calculations of financial covenants. The definition of Consolidated EBITDA has been amended to include as an addition to Consolidated Net Income (i) costs and expenses incurred in connection with the Eighth Amendment not to exceed $175,000, (ii) restructuring expenses not to exceed $500,000 in any 12 month period, (iii) costs incurred with respect to the purchase and implementation of the ERP system not to exceed (A) $200,000 during each fiscal quarter in 2020 and (B) $100,000 during each fiscal quarter in 2021, and (iv) to the extent added in calculating Consolidated Net Income any portion of the PPP loan that has been forgiven and cancelled. The Eighth Amendment also amended the calculation of certain financial covenants based upon 12 month results to effectively exclude results of the quarter ended June 30, 2020. The calculation of Maximum Total Leverage Ratio has been amended, commencing with the quarter ending September 30, 2020 and through and including the quarter ending March 31, 2021, to annualize Consolidated EBITDA for the periods beginning July 1, 2020 through the date of calculation. The calculation of Minimum Debt Service Coverage Ratio for the quarters ended September 30, 2020, December 31, 2020 and March 31, 2021 are based upon results for one, two and three quarters, respectively. The Eighth Amendment further adds a Minimum Liquidity requirement to be calculated monthly through June 30, 2021 and Minimum Consolidated EBITDA for each measurement period, as defined, through June 30, 2021. The Eighth Amendment permits distributions by US Borrower to the Parent to be declared and made only after December 31, 2021 provided certain conditions are satisfied. Maturities on the Company’s Amended and Restated Credit Agreement and other long term debt obligations for the remainder of the current fiscal year and future fiscal years are as follows (in thousands): 2020 $ 1,782 2021 5,375 2022 6,112 2023 35,744 2024 1,200 Thereafter 900 Total 51,113 Discounts (334) Debt issuance costs (264) Total debt, net $ 50,515 Paycheck Protection Program Loan On April 24, 2020, the Company entered into a Promissory Note (“PPP Note”) for $6.0 million with Citizens Bank, National Association, (“PPP Lender”) pursuant to the U.S. Small Business Administration (“SBA”) Paycheck Protection Program under Title I of the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act passed by Congress and signed into law on March 27, 2020. On June 3, 2020, Congress passed the Paycheck Protection Program Flexibility Act of 2020 (the “PPP Flexibility Act”) and on June 5, 2020 it was signed into law. The PPP Flexibility Act modified certain provisions of the CARES Act. The PPP Note is unsecured, bears interest at 1.00% per annum, with principal and interest payments deferred until the earlier of (i) the PPP Lender receiving the forgiveness amount from the SBA or (ii) August 12, 2021. The PPP Note matures on April 24, 2022. The principal is payable in equal monthly installments, with interest, beginning on the first business day after the end of the deferment period. The PPP Note may be forgiven subject to the terms of the Paycheck Protection Program and PPP Flexibility Act. Additionally, certain acts of the Company, including but not limited to: (i) the failure to pay any taxes when due, (ii) becoming the subject of a proceeding under any bankruptcy or insolvency law, (iii) making an assignment for the benefit of creditors, or (iv) reorganizing, merging, consolidating or otherwise changing ownership or business structure without PPP Lender’s prior written consent, are considered events of default which grant Lender the right to seek immediate payment of all amounts owing under the PPP Note. As of June 30, 2020, none of the circumstances listed above exist at the Company.

Derivative Financial Instrument

Derivative Financial Instruments	6 Months Ended
	Jun. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Interest Rate Swap The Company holds a derivative financial instrument, in the form of an interest rate swap, as required by its Credit Agreement and Amended and Restated Credit Agreement, for the purpose of hedging certain identifiable transactions in order to mitigate risks relating to the variability of future earnings and cash flows caused by interest rate fluctuations. The Company has elected not to apply hedge accounting for financial reporting purposes. The interest rate swap is recognized in the accompanying condensed consolidated balance sheets at its fair value. Monthly settlement payments due on the interest rate swap and changes in its fair value are recognized currently in net income as interest expense in the accompanying condensed consolidated statements of operations. Effective June 30, 2016, as required under the Credit Agreement entered into during April 2016, the Company entered into an interest rate swap which requires the Company to pay a fixed rate of 1.055 percent per annum while receiving a variable rate per annum based on the one month LIBOR for a net monthly settlement based on the notional amount. The notional amount at the effective date was $16.7 million which decreased by $0.3 million each quarter until June 30, 2017, and thereafter decreased by $0.4 million each quarter until June 29, 2018, when it began decreasing by $0.5 million per quarter until it expired on June 28, 2019. Effective October 2, 2017, as required under the Second Amendment to the Credit Agreement, the Company entered into another interest rate swap which requires the Company to pay a fixed rate of 1.093 percent per annum while receiving a variable interest rate per annum based on the one month LIBOR, for a net monthly settlement based on the notional amount in effect. The notional amount at the effective date was $1.9 million which decreases by $0.1 million each quarter until it expires on September 30, 2020. Effective November 30, 2018, as required under the Amended and Restated Credit Agreement, the Company entered into another interest rate swap that requires the Company to pay a fixed rate of 3.075 percent per annum while receiving a variable interest rate per annum based on the one month LIBOR for a net monthly settlement based on the notional amount in effect. The notional amount at the effective date was $5.0 million which increased by $0.4 million each quarter until June 28, 2019 when the notional amount increased to $17.5 million due to the interest rate swap from 2016 described above expiring. Since June 28, 2019, the notional amount then decreased each quarter by $0.2 million until September 30, 2020 when the notional amount increases to $17.5 million due to the interest rate swap from 2017 above expiring. The notional amount then decreases each quarter by $0.4 million until December 31, 2021, then decreases each subsequent quarter by $0.6 million until it expires on November 8, 2023 At June 30, 2020, the fair value of all swaps was in a net liability position of $1.5 million and is included in other accrued liabilities and other long term liabilities in the condensed consolidated balance sheets. The Company paid $0.2 million and $1.0 million in net monthly settlements with respect to the interest rate swaps for the three and six months ended June 30, 2020, respectively. At June 30, 2019, the fair value of the swaps was a net liability of $1.0 million, which was included in other long term liabilities in the condensed consolidated balance sheet. The Company received $0.04 million and $0.09 million in net monthly settlements in respect to the interest rate swaps for the three and six months ended June 30, 2019. Both the change in fair value and the net monthly settlements were included in interest expense in the condensed consolidated statements of operations.

Restructuring

Restructuring	6 Months Ended
	Jun. 30, 2020
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring The Company's restructuring activities are undertaken as necessary to implement management's strategy and improve operating results. The restructuring activities generally relate to realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, either in the normal course of business or pursuant to specific restructuring programs. 2019 Restructurings Bryan Restructuring On November 7, 2019, the Company made the decision to close its manufacturing facility in Bryan, Ohio. Approximately 43 positions were eliminated as a result of the closure. The Company's decision resulted from its desire to streamline operations and to utilize some of the available excess capacity in other of our facilities. The Company has moved existing Bryan production to its manufacturing facilities in Querétaro, Mexico and LaFayette, Georgia. The Company will provide the affected employees severance pay, health benefits continuation, and job search assistance. The Company evaluated whether or not this closing met the criteria for discontinued operations and concluded that the closing did not meet the definition as it did not represent a strategic shift in the Company's operations and the Company will have continuing cash flows from the production being moved to other facilities within the Company. The Company incurred one-time severance costs as a result of this plant closure of approximately $0.3 million during the fourth quarter of 2019. The amount of other costs incurred associated with this plant closure, which primarily consist of preparing and moving existing production equipment and inventory at Bryan to other facilities and accelerated depreciation of the building right-of-use lease asset, was approximately $0.6 million during the six months ended June 30, 2020. Evansville Restructuring On July 16, 2019, the Company made the decision to close its manufacturing facility in Evansville, Indiana. The Company ceased operations at the Evansville facility during the fourth quarter of 2019, and approximately 47 positions were eliminated as a result of the closure. The Company's decision resulted from its desire to streamline operations and to utilize some of the available excess capacity in other of our facilities. The Company moved existing Evansville production to its manufacturing facilities in LaFayette, Georgia, Auburn Hills, Michigan, and Louisville, Kentucky. The Company provided the affected employees severance pay, health benefits continuation, and job search assistance. The Company evaluated whether or not this closing met the criteria for discontinued operations and concluded that the closing did not meet the definition as it did not represent a strategic shift in the Company's operations and the Company will have continuing cash flows from the production being moved to other facilities within the Company. Costs incurred in the six months ended June 30, 2020, which consisted primarily of transportation and installation of equipment and the disposal of equipment and inventory was $0.5 million. Also included in this amount is a non-cash loss related to the loss on the sale of the Evansville building. All of these costs were recorded to the restructuring expense line in continuing operations in the Company's condensed consolidated statements of operations. The Company had $0.9 million and $1.2 million of remaining lease payments for a warehouse near the Evansville, Indiana facility as of June 30, 2020 and December 29, 2019, respectively. The Company has actively secured a sublease of roughly 15% of the facility. The table below summarizes the activity in the restructuring liability for the six months ended June 30, 2020 (in thousands). Employee Termination Benefits Liability Other Exit Costs Liability Total Accrual balance at December 29, 2019 $ 438 $ 116 $ 554 Provision for estimated expenses to be incurred — 1,193 1,193 Payments made during the year and asset write offs 400 838 1,238 Accrual balance at June 30, 2020 $ 38 $ 470 $ 508

Stock Incentive Plans

Stock Incentive Plans	6 Months Ended
	Jun. 30, 2020
Share-based Payment Arrangement [Abstract]
Stock Incentive Plans	Stock Incentive Plans 2013 Stock Incentive Plan The Company’s board of directors approved a stock incentive plan (the “Plan”) in 2013. The Plan permits the Company to grant 495,000 non statutory or incentive stock options to the employees, directors and consultants of the Company. 495,000 shares of unissued common stock are reserved for the Plan. The board of directors has the authority to determine the participants to whom stock options shall be awarded as well as any restrictions to be placed upon the awards. The exercise price cannot be less than the fair value of the underlying shares at the time the stock options are issued and the maximum length of an award is ten years. The fair value of each option award is estimated on the grant date using a Black Scholes option pricing model that uses the weighted average assumptions noted in the following tables. The expected volatility is based on the historical volatility of the stock of comparable companies. The expected term of the awards was estimated based on findings from academic studies investigating the average holding period for options adjusted for the Company’s size and risk factors. The risk free rate for periods within the contractual life of the option is based on the United States Treasury yield curve in effect at the time of grant. On February 25, 2020, the compensation committee of the board of directors approved the issuance of 7,500 non statutory stock option awards to employees of the Company. All of the awards have an exercise price of $3.32 per share with a weighted average grant date fair value of $1.64 per share. These options vest 40% on February 25, 2021 and 20% on each of February 25, 2022, 2023, and 2024. February 25, 2020 Expected volatility 52.00 % Dividend yield — % Expected term (in years) 6 Risk-free rate 1.21 % On April 6, 2020, the compensation committee of the board of directors approved the issuance of 12,500 non statutory stock option awards to the Company’s new Chief Financial Officer (“CFO”) with an exercise price of $2.36 per share. These awards vest 50 percent once the closing price of the Company's common stock is in excess of $7.50 per share for 10 out of 20 consecutive trading days and an additional 50 percent once the closing price of the Company's common stock is in excess of $12.50 per share for 10 out of 20 consecutive trading days. April 6, 2020 Expected volatility 76.00 % Dividend yield — % Expected term (in years) 6 Risk-free rate 0.51 % 2014 Omnibus Performance Award Plan In 2014, the board of directors and stockholders adopted the Unique Fabricating, Inc. 2014 Omnibus Performance Award Plan, or the 2014 Plan. The 2014 Plan provides for the grant of cash awards, stock options, stock appreciation rights, or SARs, shares of restricted stock and restricted stock units, or RSUs, performance shares and performance units. The 2014 Plan originally authorized the grant of awards relating to 250,000 shares of our common stock. In the event of any transaction that causes a change in capitalization, the Compensation Committee, such other committee administering the 2014 Plan or the board of directors will make such adjustments to the number of shares of common stock delivered, and the number and/or price of shares of common stock subject to outstanding awards granted under the 2014 Plan, as it deems appropriate and equitable to prevent dilution or enlargement of participants’ rights. An amendment approved in March of 2016 by our board of directors which was approved by our stockholders at our annual meeting of stockholders in June 2016, increased the number of shares authorized for grant of awards under the 2014 Plan to a total of 450,000 shares of our common stock. In July 2020, an additional amendment was approved at our annual meeting of stockholders, which increased the number of shares authorized for grant of awards under the 2014 Plan to a total of 700,000 shares of our common stock. The fair value of each of the option awards described below is estimated on the grant date using a Black Scholes option pricing model that uses the weighted average assumptions noted in the following tables. The expected volatility is based on the historical volatility of the stock of comparable companies. The expected term of the awards was estimated based on findings from academic studies investigating the average holding period for options for adjusted for the Company’s size and risk factors. The risk free rate for periods within the contractual life of the option is based on the United States Treasury yield curve in effect at the time of grant. On February 25, 2020, the compensation committee of the board of directors approved the issuance of 15,000 incentive stock option awards to employees of the Company with an exercise price of $3.32 per share. These awards vest 50 percent once the closing price of the Company's common stock is in excess of $7.50 per share for 10 out of 20 consecutive trading days and an additional 50 percent once the closing price of the Company's common stock is in excess of $12.50 per share for 10 out of 20 consecutive trading days. The Company estimated the grant-date fair value of the awards subject to these market conditions using a Monte Carlo simulation model, using the following assumptions: risk free interest rate of 1.21% and annualized volatility of 52.0%. Also on February 25, 2020, the compensation committee of the board of directors approved the issuance of 7,500 non statutory stock option awards to employees of the Company. All of the awards have an exercise price of $3.32 per share with a weighted average grant date fair value of $1.64 per share. These options vest 40% on February 25, 2021 and 20% on each of February 25, 2022, 2023, and 2024. February 25, 2020 Expected volatility 52.00 % Dividend yield — % Expected term (in years) 6 Risk-free rate 1.21 % On April 6, 2020, the compensation committee of the board of directors approved the issuance of 25,000 non statutory stock option awards to the Company’s new CFO with an exercise price of $2.36 per share. These awards vest 40 percent on April 6, 2021 and an additional 20 percent on each of April 6, 2022, 2023, and 2024. On April 6, 2020, the compensation committee of the board of directors approved the issuance of 12,500 incentive stock option awards to the Company’s new CFO with an exercise price of $2.36 per share. These awards vest 50 percent once the closing price of the Company's common stock is in excess of $7.50 per share for 10 out of 20 consecutive trading days and an additional 50 percent once the closing price of the Company's common stock is in excess of $12.50 per share for 10 out of 20 consecutive trading days. April 6, 2020 Expected volatility 76.00 % Dividend yield 0.00 % Expected term (in years) 6 Risk-free rate 0.51 % A summary of option activity under both plans is presented below: Number of Weighted Weighted Average Remaining Aggregate Intrinsic Value (1) (dollars in thousands, except share data and exercise price) Outstanding at December 29, 2019 676,480 $ 5.48 7.1 $ 471,000 Granted 80,000 $ 2.72 9.7 Exercised — $ — 0.0 Forfeited or expired (2) 95,000 $ 6.91 0.0 Outstanding at June 30, 2020 661,480 $ 4.94 7.3 $ — Vested and exercisable at June 30, 2020 296,480 $ 7.43 4.6 $ — ———————————— (1) The aggregate intrinsic value above is obtained by subtracting the weighted average exercise price from the estimated fair value of the underlying shares and multiplying this result by the related number of options outstanding and exercisable as of the period end date. As of June 30, 2020, there is no intrinsic value as the exercise prices are greater than the fair value. The estimated fair value of the shares is based on the closing price of the stock of $3.19 as of June 30, 2020 and $4.01 as of December 29, 2019. (2) Includes the 65,000 shares forfeited by the Company’s former Chief Financial Officer as a result of his October 2019 departure. The Company recorded compensation expense of $31.8 thousand and $54.6 thousand for the three and six months ended June 30, 2020, and $65.7 thousand and $98.4 thousand for the three and six months ended June 30, 2019, in its condensed consolidated statements of operations, as a component of sales, general and administrative expenses. The income tax (expense) benefit related to share based compensation expense was immaterial for all periods presented. As of June 30, 2020, there was $332.5 thousand of total unrecognized compensation cost related to non-vested stock option awards under the plans. That cost is expected to be recognized over a weighted average period of 5.3 years.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesFor interim tax reporting we estimate our annual effective tax rate and apply it to our year to date income before income taxes. The tax effects of unusual or infrequently occurring items, including changes in judgment about valuation allowances and the effect of changes in tax laws or rates, are reported in the interim period in which they occur, if applicable.  Income tax (benefit) expense for the three and six months ended June 30, 2020 was $(1.1) million and $(1.7) million, respectively, compared to $(0.4) million and $(0.3) million for the three and six months ended June 30, 2019, respectively. During the three and six months ended June 30, 2020, the effective tax rates were 19.7% and 20.0%, respectively. The differences between the effective tax rates and the statutory rate of 21.0% were primarily due to benefit of tax credits in the U.S. partially offset by earnings generated in Mexico and Canada, which both have higher statutory income tax rates than the U.S., and U.S. taxation of foreign earnings under the Global Intangible Low-Taxed Income (GILTI) provisions.

Leases

Leases	6 Months Ended
	Jun. 30, 2020
Leases [Abstract]
Leases	Leases The Company records a right-of-use (“ROU”) asset and lease liability for substantially all leases for which it is a lessee, in accordance with ASC 842. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. The Company has no significant lease agreements in place for which the Company is a lessor. At inception of a contract, the Company considers all relevant facts and circumstances to assess whether or not the contract represents a lease by determining whether or not the contract conveys the right to control the use of an identified asset, either explicit or implicit, for a period of time in exchange for consideration. The Company leases certain industrial spaces, office space, land, and equipment. Some leases include one or more options to renew, with renewal terms that can extend the lease term from generally one Leased assets and liabilities included within the condensed consolidated balance sheets consist of the following (in thousands): Classification June 30, 2020 Right-of-Use-Assets Operating Operating leases $ 10,965 Liabilities Current Operating Other accrued liabilities $ 2,815 Non-current Operating Non-current liabilities 9,076 Total lease liabilities $ 11,891 Lease costs included in the condensed consolidated statements of operations consist of the following (in thousands): Classification June 30, 2020 Lease cost Cost of sales, selling expenses and general and administrative expense $ 1,605 Maturity of the Company’s lease liabilities as of June 30, 2020 is as follows (in thousands): 2020 (remainder) $ 1,516 2021 2,838 2022 1,979 2023 1,203 2024 1,116 Thereafter 6,458 Total lease payments 15,110 Less: interest 3,220 Present value of lease payments $ 11,891 As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Remaining lease term and discount rates are as follows: June 30, 2020 Weighted average remaining lease term (years) 7.4 Weighted average discount rate 6.4 % Lease costs included in the condensed consolidated statements of cash flows are as follows (in thousands): Six Months Ended June 30, 2020 Cash paid for amounts included in the measurement of lease liabilities Operating cash outflows from operating leases $ 1,602

Retirement Plans

Retirement Plans	6 Months Ended
	Jun. 30, 2020
Retirement Benefits [Abstract]
Retirement Plans	Retirement PlansThe Company maintains a defined contribution plan covering certain full time salaried employees. Employees can make elective contributions to the plan. The Company contributes a match on 100 percent of an employee’s contribution up to the first 3 percent of each employee’s total compensation and 50 percent for the next 2 percent of each employee’s total compensation. In addition, the Company, at the discretion of the board of directors, may make additional contributions to the plan on behalf of the plan participants. The Company contributed $0.1 million and $0.2 million for the three and six months ended June 30, 2020 and $0.1 million and $0.3 million for the three and six months ended June 30, 2019, respectively.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Effective March 18, 2013, the Company is a party to a management agreement with a firm related to several stockholders. The agreement initially provided for annual management fees of $0.3 million and additional fees for assistance provided with acquisitions. Effective upon completion of the Company's initial public offering, the agreement was amended to reduce the annual management fee by an amount equal to the amount, if any, of annual cash retainers and equity awards received as compensation for service on the board of directors to any person who is a related person of Taglich Private Equity, LLC or Taglich Brothers, Inc. The Company incurred management fees of $0.1 million and $0.1 million for the three and six months ended June 30, 2020, respectively and $0.1 million for and $0.1 million the three and six months ended June 30, 2019, respectively. The management agreement had an initial term of five years, expiring on March 18, 2020, and renews automatically annually for additional one year terms. The current term expires on March 18, 2021. The agreement also will terminate on the date that the Taglich Founding Investors or Taglich Equity Investors, each as defined, no longer also collectively own 50% of the equity securities owned by either of them on March 18, 2013. In 2019, following the May 6, 2019 resignation of the Company’s Chief Executive Officer, the Company entered into a services agreement with 6th Avenue Group, which is a company owned by a Board member of the Company. The services performed have been related to providing assistance for long term strategic planning for the Company as well as aiding in helping the

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Financial instruments consist of cash equivalents, accounts receivable, accounts payable and debt. The carrying amount of all significant financial instruments approximates fair value due to either the short maturity or the existence of variable interest rates that approximate prevailing market rates. Accounting standards require certain other items be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value. Fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. Level 2 inputs may include quoted prices for similar items in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related item. Level 3 fair value measurements are based primarily on management’s own estimates using inputs such as pricing models, discounted cash flow methodologies or similar techniques taking into account the characteristics of the item. In instances whereby inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each item. The Company measures its interest rate swaps at fair value on a recurring basis based primarily on Level 2 inputs using an income model based on disparity between variance and fixed interest rates, the scheduled balance of principal outstanding, yield curves and other information readily available in the market.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2020
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per ShareBasic earnings per share is computed by dividing the net income by the weighted-average number of shares outstanding during the period. Diluted earnings per share is computed giving effect to all potentially weighted average dilutive shares including stock options and warrants. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method. The following table sets forth the reconciliation of the numerator and the denominator of basic and diluted loss per share for the three and six months ended June 30, 2020 and 2019 (dollars in thousands, except per share amounts): Three Months Ended June 30, 2020 Three Months Ended June 30, 2019 Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 Numerator: Net (loss) $ (4,322) $ (7,624) $ (6,624) $ (7,812) Denominator: Weighted average shares outstanding, basic 9,779,147 9,779,147 9,779,147 9,779,147 Dilutive effect of stock-based awards — — — — Weighted average share outstanding, diluted 9,779,147 9,779,147 9,779,147 9,779,147 Basic loss per share $ (0.44) $ (0.78) $ (0.68) $ (0.80) Diluted loss per share $ (0.44) $ (0.78) $ (0.68) $ (0.80) The effect of certain common stock equivalents were excluded from the computation of weighted average diluted shares outstanding for the three and six months ended June 30, 2020 and 2019, as inclusion would have resulted in anti-dilution. A summary of these anti-dilutive common stock equivalents is provided in the table below: Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 Number of options 661,480 593,680 Exercise price of options $2.36 - $12.58 $7.65 - $12.58 Warrants (1) 142,185 142,185 Exercise price of warrants $3.33 - $11.88 $3.33 - $11.88 _________________________________

Contingencies

Contingencies	6 Months Ended
	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Contingencies	ContingenciesThe Company is engaged from time to time in legal matters and proceedings arising out of its normal course of business. The Company establishes a liability related to its legal proceedings and claims when it has determined that it is probable that the Company has incurred a liability and the related amount can be reasonably estimated. If the Company determines that an obligation is reasonably possible, the Company will, if material, disclose the nature of the loss contingency and the estimated range of possible loss, or include a statement that no estimate of loss can be made. While uncertainties are inherent in the final outcome of such matters, the Company believes that there are no pending proceedings in which the Company is currently involved that will have a material effect on its financial position, results of operations or cash flow.

Restatement

Restatement	6 Months Ended
	Jun. 30, 2020
Accounting Changes and Error Corrections [Abstract]
Restatement	RestatementSubsequent to the issuance of the Company’s Quarterly Report on Form 10-Q for the three and six months ended June 30, 2020, the Company’s management identified errors impacting certain accounts. The errors were not detected on a timely basis due to control failures related to account reconciliation preparation and review. As a result, the Company’s condensed consolidated financial statements and corresponding notes for the three and six months ended June 30, 2020 have been restated from the amounts previously reported to reflect the correct balances as presented below. Condensed Consolidated Balance Sheet as of June 30, 2020: June 30, 2020 As Previously Reported Adjustments As Restated (dollars in thousands) Cash and cash equivalents $ 4,737 $ (639) $ 4,098 Inventory, net $ 15,137 $ (327) $ 14,810 Prepaid expenses and other $ 3,654 $ (80) $ 3,574 Total current assets $ 40,602 $ (1,046) $ 39,556 Property, plant, and equipment, net $ 22,815 $ (36) $ 22,779 Deferred tax asset $ 926 $ 293 $ 1,219 Total assets $ 108,325 $ (789) $ 107,536 Accrued compensation $ 993 $ 151 $ 1,144 Other accrued liabilities $ 4,312 $ 231 $ 4,543 Total current liabilities $ 15,936 $ 382 $ 16,318 Total liabilities $ 74,263 $ 382 $ 74,645 Accumulated deficit $ (12,014) $ (1,171) $ (13,185) Total stockholders’ equity $ 34,062 $ (1,171) $ 32,891 Total liabilities and stockholders’ equity $ 108,325 $ (789) $ 107,536 Condensed Consolidated Statement of Operations for the three and six months ended June 30, 2020: Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated (dollars in thousands, except per share amounts) Net sales $ 14,759 $ 216 $ 14,975 $ 49,736 $ (100) $ 49,636 Cost of sales $ 13,019 $ 115 $ 13,134 $ 40,921 $ 1,283 $ 42,204 Gross profit $ 1,740 $ 101 $ 1,841 $ 8,815 $ (1,383) $ 7,432 Selling, general, and administrative expenses $ 6,281 $ 62 $ 6,343 $ 12,146 $ 81 $ 12,227 Operating loss $ (4,814) $ 39 $ (4,775) $ (4,524) $ (1,464) $ (5,988) (Loss) before income tax (benefit) $ (5,420) $ 40 $ (5,380) $ (6,819) $ (1,464) $ (8,283) Income tax (benefit) $ (1,103) $ 45 $ (1,058) $ (1,366) $ (293) $ (1,659) Net loss $ (4,317) $ (5) $ (4,322) $ (5,453) $ (1,171) $ (6,624) Net loss per share: Basic $ (0.44) $ — $ (0.44) $ (0.56) $ (0.12) $ (0.68) Diluted $ (0.44) $ — $ (0.44) $ (0.56) $ (0.12) $ (0.68) Condensed Consolidated Statement of Stockholders’ Equity for the six months ended June 30, 2020: As Previously Reported Adjustments As Restated (dollars in thousands) Accumulated deficit: Net loss – three months ended March 31, 2020 $ (1,137) $ (1,165) $ (2,302) Accumulated deficit balance – March 31, 2020 $ (7,697) $ (1,166) $ (8,863) Net loss – three months ended June 30, 2020 $ (4,317) $ (5) $ (4,322) Accumulated deficit balance – June 30, 2020 $ (12,014) $ (1,171) $ (13,185) Total stockholders' equity: Net loss – three months ended March 31, 2020 $ (1,137) $ (1,165) $ (2,302) Total stockholders' equity balance – March 31, 2020 $ 38,347 $ (1,166) $ 37,181 Net loss – three months ended June 30, 2020 $ (4,317) $ (5) $ (4,322) Total stockholders' equity balance – June 30, 2020 $ 34,062 $ (1,171) $ 32,891 Condensed Consolidated Statement of Cash Flows for the six months ended June 30, 2020: Six Months Ended June 30, 2020 As Previously Reported Adjustments As Restated (dollars in thousands) Cash Flows from Operating Activities: Net loss $ (5,453) $ (1,171) $ (6,624) Adjustments to reconcile net loss to net cash provided by operating activities: Deferred income taxes $ (1,571) $ (293) $ (1,864) Inventory $ (2,021) $ 327 $ (1,694) Prepaid expenses and other assets $ (1,889) $ 80 $ (1,809) Accrued and other liabilities $ (983) $ 382 $ (601) Net cash provided by operating activities $ 1,368 $ (675) $ 693 Cash Flows from Investing Activities: Capital expenditures $ (796) $ 36 $ (760) Net cash provided by (used in) investing activities $ 88 $ 36 $ 124 Cash and cash equivalents: Net increase (decrease) in cash and cash equivalents $ 4,087 $ (639) $ 3,448 Cash and cash equivalents at end of period $ 4,737 $ (639) $ 4,098

Nature of Business and Basis _2

Nature of Business and Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company’s condensed consolidated financial statements have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principals have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements contain all material adjustments (consisting only of normal recurring adjustments) necessary to present fairly the consolidated financial position of the Company, its results of operations, and its cash flows. The interim results for the periods presented may not be indicative of the Company's actual annual results. The Company’s Statement of Cash Flows, presented above, has been recast to show the gross movements of payments on and proceeds from our revolving credit facility. The Company’s management believes this presentation provides a more transparent view of the activity, as such prior periods have been recast for comparability. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K/A for the year ended December 29, 2019.
Change in Quarter and Year-End	Change in Quarter and Year-EndHistorically, the Company’s quarterly periods ended on the Sunday closest to the end of the calendar quarterly period. For 2019, the quarters and year to date period, which were 13 weeks, respectively, ended on March 31, June 30, September 29, and December 29, 2019. On March 13, 2020, the Company’s board of directors approved changing our quarterly periods to match calendar quarterly periods. The Company expects the impact of this change on our 2020 result of operations to be immaterial. All year, quarter, and three month references prior to 2020 relate to the Company’s fiscal year and fiscal quarters, unless otherwise stated. For ease of presentation, three and six months ended is used throughout this Quarterly Report on Form 10-Q to represent both the current year calendar quarterly periods and the prior year fiscal year periods.
New Accounting Pronouncements	In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses,” which introduced new guidance for an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Instruments in scope include loans, held-to-maturity debt securities, and net investments in leases as well as reinsurance and trade receivables. In November 2018, the FASB issued ASU 2018-19, which clarifies that operating lease receivables are outside the scope of the new standard. In November 2019, the FASB issued ASU 2019-10, which established the effective date of the new standard for smaller reporting companies as fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact, if any the adoption of the new credit losses model will have on its financial statements.In February 2016, the FASB issued ASU 2016-2, Leases (Topic 842). This update requires lessees to recognize, on the balance sheet, assets and liabilities for the rights and obligations created by leases of greater than twelve months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. We have identified our existing lease contracts and calculated the right of use assets, which are reflected in Other Assets on the Condensed Consolidated Balance Sheets, and lease liabilities, which are reflected in the Other Accrued Liabilities on the Condensed Consolidated Balance Sheets. This guidance was effective for the Company as of January 1, 2020. Adoption of the new standard resulted in the recording of right-of-use assets and liabilities of $12.1 million and $12.8 million as of January 1, 2020. The FASB has issued further ASUs related to the standard providing an optional transition method allowing entities to not recast comparative periods. The Company elected the practical expedients upon transition that retained the lease classification and initial direct costs for any leases that exist prior to adoption of the standard.
Revenue Recognition	Revenue is recognized by the Company once all performance obligations under the terms of a contract with the Company's customers are satisfied. Generally this occurs with the transfer of control to a customer of its transportation, appliance, and other products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring its products. The Company’s payment terms vary by the type and location of its customers and the products offered. The term between invoicing and when payment is due is not significant. In general for sales arrangements, the Company deems control to transfer at a single point in time and recognizes revenue when it ships products from its manufacturing facilities to its customers. Once a product has shipped, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to transfer upon shipment because the Company has a present right to payment at that time, the customer has legal title to the asset, and the customer has significant risks and rewards of ownership of the asset. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. Contract Balances
Fair Value Measurement	Financial instruments consist of cash equivalents, accounts receivable, accounts payable and debt. The carrying amount of all significant financial instruments approximates fair value due to either the short maturity or the existence of variable interest rates that approximate prevailing market rates. Accounting standards require certain other items be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value. Fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. Level 2 inputs may include quoted prices for similar items in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related item. Level 3 fair value measurements are based primarily on management’s own estimates using inputs such as pricing models, discounted cash flow methodologies or similar techniques taking into account the characteristics of the item. In instances whereby inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each item. The Company measures its interest rate swaps at fair value on a recurring basis based primarily on Level 2 inputs using an income model based on disparity between variance and fixed interest rates, the scheduled balance of principal outstanding, yield curves and other information readily available in the market.

Nature of Business and Basis _3

Nature of Business and Basis of Presentation (Tables)	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Schedules of Concentration of Risk	The following table presents the Company's sales directly and indirectly to General Motors Company (GM), Fiat Chrysler Automobiles (FCA), and Ford Motor Company (Ford) as a percentage of total net sales: Three Months Ended June 30, 2020 Three Months Ended June 30, 2019 Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 General Motors Company 16 % 17 % 16 % 18 % Fiat Chrysler Automobiles 11 % 16 % 15 % 15 % Ford Motor Company 12 % 12 % 14 % 11 % Three Months Ended June 30, 2020 Three Months Ended June 30, 2019 Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 Mexico 20 % 19 % 22 % 19 % Canada 12 % 8 % 9 % 7 % Other — % 1 % — % — % The following table presents the percentage of the Company's total net sales represented by net sales from customers located in Mexico, Canada, and other foreign countries: Three Months Ended June 30, 2020 Three Months Ended June 30, 2019 Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 Mexico 17 % 17 % 21 % 18 % Canada 9 % 10 % 8 % 10 % Other — % 1 % — % 1 %

Revenues (Tables)

Revenues (Tables)	6 Months Ended
	Jun. 30, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table presents the Company's net sales disaggregated by major sales channel for the three and six months ended June 30, 2020 and 2019 (in thousands): Three Months Ended June 30, 2020 Three Months Ended June 30, 2019 Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 Net Sales Transportation $ 11,290 $ 33,517 $ 42,986 $ 67,532 Appliance 2,132 3,504 4,912 7,258 Other 1,553 1,868 1,738 3,566 Total $ 14,975 $ 38,889 $ 49,636 $ 78,356

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Jun. 30, 2020
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventories consist of the following (in thousands): June 30, December 29, Raw materials $ 9,455 $ 7,963 Work in progress 718 129 Finished goods 4,637 4,955 Total inventory $ 14,810 $ 13,047

Property, Plant, and Equipmen_2

Property, Plant, and Equipment, Net (Tables)	6 Months Ended
	Jun. 30, 2020
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant, and equipment, net consists of the following (in thousands): June 30, December 29, Depreciable Land $ 1,663 $ 1,663 Buildings 5,798 5,934 23 – 40 Shop equipment 23,037 22,982 7 – 10 Leasehold improvements 1,248 1,234 3 – 10 Office equipment 1,829 1,866 3 – 7 Mobile equipment 153 190 3 Construction in progress 2,302 1,543 Total cost 36,030 35,412 Less: Accumulated depreciation 13,250 11,997 Net property, plant, and equipment, net $ 22,779 $ 23,415

Long-term Debt (Tables)

Long-term Debt (Tables)	6 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Schedule of Long-Term Debt	Long term debt consists of the following (in thousands): June 30, December 29, U.S. Small Business Administration Paycheck Protection Program loan (PPP Note), payable in equal monthly installments on the first day after the deferment period. The PPP Note is unsecured and bears interest at 1% per annum. The PPP Note may be forgiven subject to the terms of the Paycheck Protection Program. $ 5,999 $ — New US Term Loan, payable to lenders in quarterly installments of $0.3 million through September 30, 2020, $0.6 million through September 30, 2021, and $0.8 million through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5% per annum at June 30, 2020. At June 30, 2020, the balance of the New US Term Loan is presented net of a debt discount of $0.3 million from costs paid to or on behalf of the lenders. 23,743 24,383 CA Term Loan, payable to lenders in quarterly installments of $0.4 million through November 7, 2023, with a lump sum due at maturity. The effective interest rate was 5% per annum at June 30, 2020. At June 30, 2020, the balance of the CA Term Loan is presented net of a debt discount of $0.1 million from costs paid to or on behalf of the lenders. 9,648 10,384 Capital expenditure line payable to lenders in quarterly installments of 7.5% per annum of the outstanding principal balance commencing December 31, 2019 through September 30, 2020, 10% per annum through September 30, 2021, and 12.5% per annum through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5% per annum at June 30, 2020. 1,251 1,300 Total debt excluding Revolver 40,641 36,067 Less current maturities 2,847 2,847 Long-term debt – Less current maturities $ 37,794 $ 33,220
Schedule of Maturities of Long-Term Debt	Maturities on the Company’s Amended and Restated Credit Agreement and other long term debt obligations for the remainder of the current fiscal year and future fiscal years are as follows (in thousands): 2020 $ 1,782 2021 5,375 2022 6,112 2023 35,744 2024 1,200 Thereafter 900 Total 51,113 Discounts (334) Debt issuance costs (264) Total debt, net $ 50,515

Restructuring (Tables)

Restructuring (Tables)	6 Months Ended
	Jun. 30, 2020
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Liability	The table below summarizes the activity in the restructuring liability for the six months ended June 30, 2020 (in thousands). Employee Termination Benefits Liability Other Exit Costs Liability Total Accrual balance at December 29, 2019 $ 438 $ 116 $ 554 Provision for estimated expenses to be incurred — 1,193 1,193 Payments made during the year and asset write offs 400 838 1,238 Accrual balance at June 30, 2020 $ 38 $ 470 $ 508

Stock Incentive Plans (Tables)

Stock Incentive Plans (Tables)	6 Months Ended
	Jun. 30, 2020
Share-based Payment Arrangement [Abstract]
Schedule of Stock Option Valuation Assumptions	February 25, 2020 Expected volatility 52.00 % Dividend yield — % Expected term (in years) 6 Risk-free rate 1.21 % April 6, 2020 Expected volatility 76.00 % Dividend yield — % Expected term (in years) 6 Risk-free rate 0.51 % February 25, 2020 Expected volatility 52.00 % Dividend yield — % Expected term (in years) 6 Risk-free rate 1.21 % April 6, 2020 Expected volatility 76.00 % Dividend yield 0.00 % Expected term (in years) 6 Risk-free rate 0.51 %
Schedule of Stock Options and Stock Appreciation Rights Award Activity	A summary of option activity under both plans is presented below: Number of Weighted Weighted Average Remaining Aggregate Intrinsic Value (1) (dollars in thousands, except share data and exercise price) Outstanding at December 29, 2019 676,480 $ 5.48 7.1 $ 471,000 Granted 80,000 $ 2.72 9.7 Exercised — $ — 0.0 Forfeited or expired (2) 95,000 $ 6.91 0.0 Outstanding at June 30, 2020 661,480 $ 4.94 7.3 $ — Vested and exercisable at June 30, 2020 296,480 $ 7.43 4.6 $ — ———————————— (1) The aggregate intrinsic value above is obtained by subtracting the weighted average exercise price from the estimated fair value of the underlying shares and multiplying this result by the related number of options outstanding and exercisable as of the period end date. As of June 30, 2020, there is no intrinsic value as the exercise prices are greater than the fair value. The estimated fair value of the shares is based on the closing price of the stock of $3.19 as of June 30, 2020 and $4.01 as of December 29, 2019. (2) Includes the 65,000 shares forfeited by the Company’s former Chief Financial Officer as a result of his October 2019 departure.

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2020
Leases [Abstract]
Balance Sheet and Weighted-Average Lease Information	Leased assets and liabilities included within the condensed consolidated balance sheets consist of the following (in thousands): Classification June 30, 2020 Right-of-Use-Assets Operating Operating leases $ 10,965 Liabilities Current Operating Other accrued liabilities $ 2,815 Non-current Operating Non-current liabilities 9,076 Total lease liabilities $ 11,891 June 30, 2020 Weighted average remaining lease term (years) 7.4 Weighted average discount rate 6.4 %
Lease Cost Information	Lease costs included in the condensed consolidated statements of operations consist of the following (in thousands): Classification June 30, 2020 Lease cost Cost of sales, selling expenses and general and administrative expense $ 1,605 Lease costs included in the condensed consolidated statements of cash flows are as follows (in thousands): Six Months Ended June 30, 2020 Cash paid for amounts included in the measurement of lease liabilities Operating cash outflows from operating leases $ 1,602
Lease Maturity	Maturity of the Company’s lease liabilities as of June 30, 2020 is as follows (in thousands): 2020 (remainder) $ 1,516 2021 2,838 2022 1,979 2023 1,203 2024 1,116 Thereafter 6,458 Total lease payments 15,110 Less: interest 3,220 Present value of lease payments $ 11,891

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the reconciliation of the numerator and the denominator of basic and diluted loss per share for the three and six months ended June 30, 2020 and 2019 (dollars in thousands, except per share amounts): Three Months Ended June 30, 2020 Three Months Ended June 30, 2019 Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 Numerator: Net (loss) $ (4,322) $ (7,624) $ (6,624) $ (7,812) Denominator: Weighted average shares outstanding, basic 9,779,147 9,779,147 9,779,147 9,779,147 Dilutive effect of stock-based awards — — — — Weighted average share outstanding, diluted 9,779,147 9,779,147 9,779,147 9,779,147 Basic loss per share $ (0.44) $ (0.78) $ (0.68) $ (0.80) Diluted loss per share $ (0.44) $ (0.78) $ (0.68) $ (0.80)
Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share	A summary of these anti-dilutive common stock equivalents is provided in the table below: Six Months Ended June 30, 2020 Six Months Ended June 30, 2019 Number of options 661,480 593,680 Exercise price of options $2.36 - $12.58 $7.65 - $12.58 Warrants (1) 142,185 142,185 Exercise price of warrants $3.33 - $11.88 $3.33 - $11.88 _________________________________

Restatement (Tables)

Restatement (Tables)	6 Months Ended
	Jun. 30, 2020
Accounting Changes and Error Corrections [Abstract]
Prior Period Adjustments, Balance Sheet	Condensed Consolidated Balance Sheet as of June 30, 2020: June 30, 2020 As Previously Reported Adjustments As Restated (dollars in thousands) Cash and cash equivalents $ 4,737 $ (639) $ 4,098 Inventory, net $ 15,137 $ (327) $ 14,810 Prepaid expenses and other $ 3,654 $ (80) $ 3,574 Total current assets $ 40,602 $ (1,046) $ 39,556 Property, plant, and equipment, net $ 22,815 $ (36) $ 22,779 Deferred tax asset $ 926 $ 293 $ 1,219 Total assets $ 108,325 $ (789) $ 107,536 Accrued compensation $ 993 $ 151 $ 1,144 Other accrued liabilities $ 4,312 $ 231 $ 4,543 Total current liabilities $ 15,936 $ 382 $ 16,318 Total liabilities $ 74,263 $ 382 $ 74,645 Accumulated deficit $ (12,014) $ (1,171) $ (13,185) Total stockholders’ equity $ 34,062 $ (1,171) $ 32,891 Total liabilities and stockholders’ equity $ 108,325 $ (789) $ 107,536
Prior Period Adjustments, Statement of Operations	Condensed Consolidated Statement of Operations for the three and six months ended June 30, 2020: Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated (dollars in thousands, except per share amounts) Net sales $ 14,759 $ 216 $ 14,975 $ 49,736 $ (100) $ 49,636 Cost of sales $ 13,019 $ 115 $ 13,134 $ 40,921 $ 1,283 $ 42,204 Gross profit $ 1,740 $ 101 $ 1,841 $ 8,815 $ (1,383) $ 7,432 Selling, general, and administrative expenses $ 6,281 $ 62 $ 6,343 $ 12,146 $ 81 $ 12,227 Operating loss $ (4,814) $ 39 $ (4,775) $ (4,524) $ (1,464) $ (5,988) (Loss) before income tax (benefit) $ (5,420) $ 40 $ (5,380) $ (6,819) $ (1,464) $ (8,283) Income tax (benefit) $ (1,103) $ 45 $ (1,058) $ (1,366) $ (293) $ (1,659) Net loss $ (4,317) $ (5) $ (4,322) $ (5,453) $ (1,171) $ (6,624) Net loss per share: Basic $ (0.44) $ — $ (0.44) $ (0.56) $ (0.12) $ (0.68) Diluted $ (0.44) $ — $ (0.44) $ (0.56) $ (0.12) $ (0.68)
Prior Period Adjustments, Statement of Stockholders Equity	Condensed Consolidated Statement of Stockholders’ Equity for the six months ended June 30, 2020: As Previously Reported Adjustments As Restated (dollars in thousands) Accumulated deficit: Net loss – three months ended March 31, 2020 $ (1,137) $ (1,165) $ (2,302) Accumulated deficit balance – March 31, 2020 $ (7,697) $ (1,166) $ (8,863) Net loss – three months ended June 30, 2020 $ (4,317) $ (5) $ (4,322) Accumulated deficit balance – June 30, 2020 $ (12,014) $ (1,171) $ (13,185) Total stockholders' equity: Net loss – three months ended March 31, 2020 $ (1,137) $ (1,165) $ (2,302) Total stockholders' equity balance – March 31, 2020 $ 38,347 $ (1,166) $ 37,181 Net loss – three months ended June 30, 2020 $ (4,317) $ (5) $ (4,322) Total stockholders' equity balance – June 30, 2020 $ 34,062 $ (1,171) $ 32,891
Prior Period Adjustments, Statement of Cash Flows	Condensed Consolidated Statement of Cash Flows for the six months ended June 30, 2020: Six Months Ended June 30, 2020 As Previously Reported Adjustments As Restated (dollars in thousands) Cash Flows from Operating Activities: Net loss $ (5,453) $ (1,171) $ (6,624) Adjustments to reconcile net loss to net cash provided by operating activities: Deferred income taxes $ (1,571) $ (293) $ (1,864) Inventory $ (2,021) $ 327 $ (1,694) Prepaid expenses and other assets $ (1,889) $ 80 $ (1,809) Accrued and other liabilities $ (983) $ 382 $ (601) Net cash provided by operating activities $ 1,368 $ (675) $ 693 Cash Flows from Investing Activities: Capital expenditures $ (796) $ 36 $ (760) Net cash provided by (used in) investing activities $ 88 $ 36 $ 124 Cash and cash equivalents: Net increase (decrease) in cash and cash equivalents $ 4,087 $ (639) $ 3,448 Cash and cash equivalents at end of period $ 4,737 $ (639) $ 4,098

Nature of Business and Basis _4

Nature of Business and Basis of Presentation - Narrative (Details) - segment	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2020
Concentration Risk [Line Items]
Number of reportable segments		1
Customer concentration risk | Direct Company Sales | General Motors Company
Concentration Risk [Line Items]
Concentration risk (percentage)	7.00%	7.00%
Labor force concentration risk | Workforce Subject to Collective Bargaining Arrangements | Collective Bargaining Arrangements Expiring August 2022
Concentration Risk [Line Items]
Concentration risk (percentage)		38.00%
Labor force concentration risk | Workforce Subject to Collective Bargaining Arrangements | Collective Bargaining Arrangements Expiring February 2023
Concentration Risk [Line Items]
Concentration risk (percentage)		6.00%

Nature of Business and Basis _5

Nature of Business and Basis of Presentation - Customers' Net Sales as a Percentage of Total Net Sales (Details) - Sales revenue, net - Customer concentration risk	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
General Motors Company
Product Information [Line Items]
Concentration risk (percentage)	16.00%	17.00%	16.00%	18.00%
Fiat Chrysler Automobiles
Product Information [Line Items]
Concentration risk (percentage)	11.00%	16.00%	15.00%	15.00%
Ford Motor Company
Product Information [Line Items]
Concentration risk (percentage)	12.00%	12.00%	14.00%	11.00%

Nature of Business and Basis _6

Nature of Business and Basis of Presentation - Production in Foreign Markets (Details) - Cost of Goods and Service Benchmark - Geographic Concentration Risk	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Mexico
Product Information [Line Items]
Concentration risk (percentage)	20.00%	19.00%	22.00%	19.00%
Canada
Product Information [Line Items]
Concentration risk (percentage)	12.00%	8.00%	9.00%	7.00%
Non-US Countries Excluding Mexico and Canada
Product Information [Line Items]
Concentration risk (percentage)	0.00%	1.00%	0.00%	0.00%

Nature of Business and Basis _7

Nature of Business and Basis of Presentation - Sales Derived from Customers Located in Foreign Countries (Details) - Geographic Concentration Risk - Sales revenue, net	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Mexico
Product Information [Line Items]
Concentration risk (percentage)	17.00%	17.00%	21.00%	18.00%
Canada
Product Information [Line Items]
Concentration risk (percentage)	9.00%	10.00%	8.00%	10.00%
Non-US Countries Excluding Mexico and Canada
Product Information [Line Items]
Concentration risk (percentage)	0.00%	1.00%	0.00%	1.00%

New Accounting Pronouncements (

New Accounting Pronouncements (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 29, 2019
Lessee, Lease, Description [Line Items]
Operating leases	$ 10,965	$ 0
Present value of lease payments	$ 11,891
Accounting Standards Update 2014-09
Lessee, Lease, Description [Line Items]
Operating leases		12,100
Present value of lease payments		$ 12,800

Revenues (Details)

Revenues (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Disaggregation of Revenue [Line Items]
Net sales	$ 14,975	$ 38,889	$ 49,636	$ 78,356
Transportation
Disaggregation of Revenue [Line Items]
Net sales	11,290	33,517	42,986	67,532
Appliance
Disaggregation of Revenue [Line Items]
Net sales	2,132	3,504	4,912	7,258
Other
Disaggregation of Revenue [Line Items]
Net sales	$ 1,553	$ 1,868	$ 1,738	$ 3,566

Inventory - Schedule of Invento

Inventory - Schedule of Inventory (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 29, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 9,455	$ 7,963
Work in progress	718	129
Finished goods	4,637	4,955
Total inventory	$ 14,810	$ 13,047

Inventory - Additional Informat

Inventory - Additional Information (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 29, 2019
Inventory [Line Items]
Allowance for obsolete inventory	$ 900	$ 1,000
Inventory, net	14,810	13,047
Mexico
Inventory [Line Items]
Inventory, net	4,100	3,600
Canada
Inventory [Line Items]
Inventory, net	$ 1,100	$ 1,000

Property, Plant, and Equipmen_3

Property, Plant, and Equipment, Net - Schedule of Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Dec. 29, 2019
Property, Plant and Equipment [Line Items]
Property, plant and equipment	$ 36,030	$ 35,412
Less: Accumulated depreciation	13,250	11,997
Net property, plant, and equipment, net	22,779	23,415
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment	1,663	1,663
Buildings
Property, Plant and Equipment [Line Items]
Property, plant and equipment	$ 5,798	5,934
Buildings | Minimum
Property, Plant and Equipment [Line Items]
Depreciable life, years	23 years
Buildings | Maximum
Property, Plant and Equipment [Line Items]
Depreciable life, years	40 years
Shop equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment	$ 23,037	22,982
Shop equipment | Minimum
Property, Plant and Equipment [Line Items]
Depreciable life, years	7 years
Shop equipment | Maximum
Property, Plant and Equipment [Line Items]
Depreciable life, years	10 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment	$ 1,248	1,234
Leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Depreciable life, years	3 years
Leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Depreciable life, years	10 years
Office equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment	$ 1,829	1,866
Office equipment | Minimum
Property, Plant and Equipment [Line Items]
Depreciable life, years	3 years
Office equipment | Maximum
Property, Plant and Equipment [Line Items]
Depreciable life, years	7 years
Mobile equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment	$ 153	190
Depreciable life, years	3 years
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment	$ 2,302	$ 1,543

Property, Plant, and Equipmen_4

Property, Plant, and Equipment, Net - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 29, 2019
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 700	$ 700	$ 1,400	$ 1,400
Property, plant, and equipment, net	22,779		22,779		$ 23,415
Mexico
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, net	4,000		4,000		4,100
Canada
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, net	$ 600		$ 600		$ 600

Long-term Debt - Additional Inf

Long-term Debt - Additional Information (Details)

Apr. 23, 2020USD ($)

Nov. 08, 2018USD ($)

Apr. 29, 2016USD ($)

Jun. 30, 2020USD ($)

Jun. 30, 2019USD ($)

Jun. 30, 2020USD ($)

Jun. 30, 2019USD ($)

Aug. 07, 2020USD ($)

Apr. 24, 2020USD ($)

Apr. 03, 2020USD ($)

Dec. 29, 2019USD ($)

Jul. 16, 2019USD ($)

Nov. 01, 2018USD ($)

Sep. 20, 2018USD ($)

Aug. 18, 2017USD ($)

Debt Instrument [Line Items]

Outstanding principal amount

$ 40,641,000

$ 40,641,000

$ 36,067,000

Debt issuance cost

300,000

300,000

300,000

Unamortized discount

334,000

334,000

400,000

Amortization expense of debt issuance costs

40,000

$ 40,000

100,000

$ 100,000

Promissory note

51,113,000

$ 51,113,000

Promissory Note | PPP under CARES Act

Debt Instrument [Line Items]

Promissory note

$ 6,000,000

Interest

1.00%

Credit agreement | Line of credit | Secured debt

Debt Instrument [Line Items]

Maximum borrowing capacity

$ 62,000,000

Maximum increase to principal amount

10,000,000

Credit agreement | Line of credit | Secured debt | Base Rate | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

1.75%

Credit agreement | Line of credit | Secured debt | Base Rate | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

3.25%

Credit agreement | Line of credit | Secured debt | LIBOR | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

2.75%

Credit agreement | Line of credit | Secured debt | LIBOR | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

4.25%

Credit agreement | Letter of credit | Revolving credit facility

Debt Instrument [Line Items]

Maximum borrowing capacity

2,000,000

New revolver | Revolving credit facility

Debt Instrument [Line Items]

Line of credit

10,100,000

$ 10,100,000

New revolver | Line of credit | Revolving credit facility

Debt Instrument [Line Items]

Maximum borrowing capacity

30,000,000

$ 700,000

$ 700,000

$ 30,000,000

$ 32,500,000

Senior notes

22,900,000

Line of credit

$ 4,000,000

Effective interest rate

5.00%

5.00%

Remaining borrowing capacity

$ 13,500,000

$ 13,500,000

US Term loan | Line of credit | Secured debt

Debt Instrument [Line Items]

Debt instrument, face amount

17,000,000

CA term loan | Line of credit | Secured debt

Debt Instrument [Line Items]

Debt instrument, face amount

$ 15,000,000

Outstanding principal amount

$ 9,648,000

$ 9,648,000

10,384,000

Effective interest rate

5.00%

5.00%

Unamortized discount

$ 100,000

$ 100,000

US Term Loan II | Line of credit | Secured debt

Debt Instrument [Line Items]

Debt instrument, face amount

$ 4,000,000

Amended And Restated Credit Agreement

Debt Instrument [Line Items]

Debt instrument, covenant, liquidity amount required, minimum

$ 5,000,000

Debt instrument, total covenant, leverage ratio

2

Debt instrument, covenant, leverage ratio after DSCR

1.10

Debt Instrument, covenant, consolidated EBITDA

$ 600,000

Amended And Restated Credit Agreement | Subsequent Event

Debt Instrument [Line Items]

Debt Instrument, Covenant, Debt Costs Maximum

$ 175,000

Debt Instrument, Covenant, Restructuring Costs Maximum

500,000

Amended And Restated Credit Agreement | Debt Instrument, Period One | Subsequent Event

Debt Instrument [Line Items]

Debt Instrument, Covenant, Purchase And Enterprise Resource Planning Costs Maximum

200,000

Amended And Restated Credit Agreement | Debt Instrument, Period Two | Subsequent Event

Debt Instrument [Line Items]

Debt Instrument, Covenant, Purchase And Enterprise Resource Planning Costs Maximum

$ 100,000

Amended And Restated Credit Agreement | PPP under CARES Act

Debt Instrument [Line Items]

Debt instrument, covenant, debt amount, maximum

$ 6,000,000

Amended And Restated Credit Agreement | Line of credit | Secured debt | Base Rate | Minimum | PPP under CARES Act

Debt Instrument [Line Items]

Basis spread on variable rate

2.00%

Amended And Restated Credit Agreement | Line of credit | Secured debt | LIBOR | Minimum | PPP under CARES Act

Debt Instrument [Line Items]

Basis spread on variable rate

1.00%

New US Term Loan | Line of credit | Secured debt

Debt Instrument [Line Items]

Outstanding principal amount

$ 23,743,000

$ 23,743,000

$ 24,383,000

Effective interest rate

5.00%

5.00%

Unamortized discount

$ 300,000

$ 300,000

Senior credit facility, second amendment | Line of credit | Revolving credit facility

Debt Instrument [Line Items]

Letters of credit outstanding, amount

100,000

100,000

Senior credit facility | Line of credit | Revolving credit facility

Debt Instrument [Line Items]

Debt issuance cost

$ 0

$ 0

US Borrower And CA Borrower | US Term loan | Line of credit | Secured debt

Debt Instrument [Line Items]

Maximum increase to principal amount

$ 26,000,000

US Borrower And CA Borrower | CA term loan | Line of credit | Secured debt

Debt Instrument [Line Items]

Outstanding principal amount

$ 12,000,000

US Borrower And CA Borrower | Amended And Restated Credit Agreement | Line of credit

Debt Instrument [Line Items]

Debt instrument, term

5 years

Debt instrument, term to fund capital expenditures

2 years

US Borrower And CA Borrower | Amended And Restated Credit Agreement | Line of credit | Revolving credit facility

Debt Instrument [Line Items]

Maximum borrowing capacity

$ 30,000,000

US Borrower And CA Borrower | New US Term Loan | Line of credit | Secured debt

Debt Instrument [Line Items]

Debt instrument, face amount

26,000,000

US Borrower And CA Borrower | US Term Loan And Term Loan II | Line of credit | Secured debt

Debt Instrument [Line Items]

Debt instrument, face amount

15,900,000

November 8, 2019 | US Borrower And CA Borrower | Amended And Restated Credit Agreement | Line of credit for capital expenditures

Debt Instrument [Line Items]

Maximum borrowing capacity

2,500,000

November 8, 2020 | US Borrower And CA Borrower | Amended And Restated Credit Agreement | Line of credit for capital expenditures

Debt Instrument [Line Items]

Maximum borrowing capacity

5,000,000

September 30, 2020 | US Borrower And CA Borrower | New US Term Loan | Line of credit | Secured debt

Debt Instrument [Line Items]

Principal payment

337,500

September 30, 2021 | US Borrower And CA Borrower | New US Term Loan | Line of credit | Secured debt

Debt Instrument [Line Items]

Principal payment

575,000

Thereafter though maturity | US Borrower And CA Borrower | New US Term Loan | Line of credit | Secured debt

Debt Instrument [Line Items]

Principal payment

$ 812,500

Long-term Debt - Schedule of Lo

Long-term Debt - Schedule of Long-Term Debt (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Dec. 29, 2019
Debt Instrument [Line Items]
Unamortized discount	$ 334	$ 400
Total debt excluding Revolver	40,641	36,067
Less current maturities	2,847	2,847
Long-term debt – Less current maturities	37,794	33,220
Line of credit for capital expenditures
Debt Instrument [Line Items]
Total debt excluding Revolver	$ 1,251	1,300
Line of credit | PPP under CARES Act | Secured debt
Debt Instrument [Line Items]
Effective interest rate	1.00%
Total debt excluding Revolver	$ 5,999	0
Line of credit | New US Term Loan | Secured debt
Debt Instrument [Line Items]
Effective interest rate	5.00%
Unamortized discount	$ 300
Total debt excluding Revolver	23,743	24,383
Line of credit | New US Term Loan | Secured debt | September 30, 2020
Debt Instrument [Line Items]
Principal payment	300
Line of credit | New US Term Loan | Secured debt | September 30, 2021
Debt Instrument [Line Items]
Principal payment	600
Line of credit | New US Term Loan | Secured debt | November 7, 2023
Debt Instrument [Line Items]
Principal payment	$ 800
Line of credit | CA term loan | Secured debt
Debt Instrument [Line Items]
Effective interest rate	5.00%
Unamortized discount	$ 100
Total debt excluding Revolver	9,648	$ 10,384
Line of credit | CA term loan | Secured debt | November 7, 2023
Debt Instrument [Line Items]
Principal payment	$ 400
Line of credit | Line of credit for capital expenditures
Debt Instrument [Line Items]
Effective interest rate	5.00%
Line of credit | Line of credit for capital expenditures | September 30, 2020
Debt Instrument [Line Items]
Percent of principal payment	7.50%
Line of credit | Line of credit for capital expenditures | September 30, 2021
Debt Instrument [Line Items]
Percent of principal payment	10.00%
Line of credit | Line of credit for capital expenditures | November 7, 2023
Debt Instrument [Line Items]
Percent of principal payment	12.50%

Long-term Debt - Schedule of Re

Long-term Debt - Schedule of Repayment of Maturities (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 29, 2019
Debt Disclosure [Abstract]
2020	$ 1,782
2021	5,375
2022	6,112
2023	35,744
2024	1,200
Thereafter	900
Total	51,113
Discounts	(334)	$ (400)
Debt issuance costs	(264)
Total debt, net	$ 50,515

Derivative Financial Instrume_2

Derivative Financial Instruments (Details) - Interest rate swap - Not designated as hedging instrument - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Nov. 30, 2018	Oct. 02, 2017	Jun. 30, 2016
Derivatives, Fair Value [Line Items]
Fixed interest rate					3.075%	1.093%	1.055%
Notional amount					$ 5,000	$ 1,900	$ 16,700
Quarterly decrease in notional amount						$ 100	300
Derivative fair value assets (liabilities)	$ 1,500	$ (1,000)	$ 1,500	$ (1,000)
Interest expense
Derivatives, Fair Value [Line Items]
Monthly settlement payments (receipts)	$ 200	$ 40	$ 1,000	$ 90
Derivative Instrument, Periodic Payment, Installment Periods Through June Twenty Nine Two Thousand Eighteen
Derivatives, Fair Value [Line Items]
Quarterly decrease in notional amount							400
Derivative Instrument, Periodic Payment, Installment Periods Through June Twenty Eight Two Thousand Nineteen
Derivatives, Fair Value [Line Items]
Notional amount					17,500
Quarterly decrease in notional amount							$ 500
Quarterly increase in notional amount					400
Derivative Instrument, Periodic Payment, Installment Periods Until September Thirty Two Thousand Twenty
Derivatives, Fair Value [Line Items]
Notional amount					17,500
Quarterly decrease in notional amount					200
Derivative Instrument, Periodic Payment, Installment Periods Until December Thirty First Twenty Twenty One
Derivatives, Fair Value [Line Items]
Quarterly decrease in notional amount					400
Derivative Instrument, Periodic Payment, Installment Periods Until November Eighth Twenty Twenty Three
Derivatives, Fair Value [Line Items]
Quarterly decrease in notional amount					$ 600

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) $ in Millions	Nov. 07, 2019employee	Jul. 16, 2019employee	Dec. 29, 2019USD ($)	Jun. 30, 2020USD ($)
Restructuring Cost and Reserve [Line Items]
Sublease of facility, percentage				15.00%
Bryan Restructuring
Restructuring Cost and Reserve [Line Items]
Number of position eliminations | employee	43
Bryan Restructuring | One-time Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred			$ 0.3
Bryan Restructuring | Other Exit Costs Liability
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred				$ 0.6
Evansville Restructuring
Restructuring Cost and Reserve [Line Items]
Number of position eliminations | employee		47
Remaining lease payments			$ 1.2	0.9
Evansville Restructuring | Other Exit Costs Liability
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred				$ 0.5

Restructuring - Schedule of Res

Restructuring - Schedule of Restructuring Liability (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Restructuring Reserve [Roll Forward]
Beginning accrual balance			$ 554
Provision for estimated expenses to be incurred	$ 273	$ 734	1,193	$ 825
Payments made during the year and asset write offs			1,238
Ending accrual balance	508		508
Employee Termination Benefits Liability
Restructuring Reserve [Roll Forward]
Beginning accrual balance			438
Provision for estimated expenses to be incurred			0
Payments made during the year and asset write offs			400
Ending accrual balance	38		38
Other Exit Costs Liability
Restructuring Reserve [Roll Forward]
Beginning accrual balance			116
Provision for estimated expenses to be incurred			1,193
Payments made during the year and asset write offs			838
Ending accrual balance	$ 470		$ 470

Stock Incentive Plans - Additio

Stock Incentive Plans - Additional Information (Details) - USD ($)	Apr. 06, 2020	Feb. 25, 2020	Jun. 11, 2019	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Jul. 31, 2020	Jun. 30, 2016	Jan. 04, 2015	Dec. 29, 2013
Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Unrecognized compensation cost				$ 332,500		$ 332,500
Compensation cost, weighted average period						5 years 3 months 18 days
Selling, General and Administrative Expenses
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Allocated share-based compensation expense				$ 31,800	$ 65,700	$ 54,600	$ 98,400
The 2013 Stock Incentive Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Number of shares reserved for future issuance (in shares)											495,000
Exercise price (in dollars per share)		$ 3.32
Weighted average grant date fair value (in dollars per share)		$ 1.64
The 2013 Stock Incentive Plan | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Number of shares available for grant (in shares)											495,000
Expiration period						10 years
Risk-free rate	0.51%	1.21%
Annualized volatility	76.00%	52.00%
The 2013 Stock Incentive Plan | Award vesting, period one | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage		40.00%
The 2013 Stock Incentive Plan | Award vesting, period two | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage		20.00%
The 2013 Stock Incentive Plan | Award vesting, period three | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage		20.00%
The 2013 Stock Incentive Plan | Award vesting, period four | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage		20.00%
The 2013 Stock Incentive Plan | Employee
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Granted (in shares)		7,500
The 2013 Stock Incentive Plan | CFO
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Granted (in shares)	12,500
Exercise price (in dollars per share)	$ 2.36
The 2013 Stock Incentive Plan | CFO | Award vesting, period one | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage	50.00%
Share price in excess (in dollars per share)	$ 7.50
The 2013 Stock Incentive Plan | CFO | Award vesting, period two | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage	50.00%
Share price in excess (in dollars per share)	$ 12.50
2014 Omnibus Performance Award Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Granted (in shares)			30,000
Exercise price (in dollars per share)		$ 3.32	$ 2.93
Weighted average grant date fair value (in dollars per share)		$ 1.64
Number of shares authorized (in shares)									450,000	250,000
2014 Omnibus Performance Award Plan | Subsequent Event
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Number of shares authorized (in shares)								700,000
2014 Omnibus Performance Award Plan | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Risk-free rate	0.51%	1.21%
Annualized volatility	76.00%	52.00%
2014 Omnibus Performance Award Plan | Employee Stock Option, Incentive
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Exercise price (in dollars per share)		$ 3.32
2014 Omnibus Performance Award Plan | Award vesting, period one | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage		40.00%
2014 Omnibus Performance Award Plan | Award vesting, period one | Employee Stock Option, Incentive
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage		50.00%
Share price in excess (in dollars per share)		$ 7.50
2014 Omnibus Performance Award Plan | Award vesting, period two | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage		20.00%
2014 Omnibus Performance Award Plan | Award vesting, period two | Employee Stock Option, Incentive
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage		50.00%
Share price in excess (in dollars per share)		$ 12.50
2014 Omnibus Performance Award Plan | Award vesting, period three | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage		20.00%
2014 Omnibus Performance Award Plan | Award vesting, period four | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage		20.00%
2014 Omnibus Performance Award Plan | Employee
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Granted (in shares)		7,500
2014 Omnibus Performance Award Plan | Employee | Employee Stock Option, Incentive
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Granted (in shares)		15,000
2014 Omnibus Performance Award Plan | CFO
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Granted (in shares)	25,000
Exercise price (in dollars per share)	$ 2.36
2014 Omnibus Performance Award Plan | CFO | Employee Stock Option, Incentive
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Granted (in shares)	12,500
Exercise price (in dollars per share)	$ 2.36
2014 Omnibus Performance Award Plan | CFO | Award vesting, period one | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage	40.00%
2014 Omnibus Performance Award Plan | CFO | Award vesting, period one | Employee Stock Option, Incentive
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage	50.00%
Share price in excess (in dollars per share)	$ 7.50
2014 Omnibus Performance Award Plan | CFO | Award vesting, period two | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage	20.00%
2014 Omnibus Performance Award Plan | CFO | Award vesting, period two | Employee Stock Option, Incentive
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage	50.00%
Share price in excess (in dollars per share)	$ 12.50
2014 Omnibus Performance Award Plan | CFO | Award vesting, period three | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage	20.00%
2014 Omnibus Performance Award Plan | CFO | Award vesting, period four | Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award vesting rights, percentage	20.00%

Stock Incentive Plans - Valuati

Stock Incentive Plans - Valuation Assumptions (Details) - Employee Stock Option	Apr. 06, 2020	Feb. 25, 2020
The 2013 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	76.00%	52.00%
Dividend yield	0.00%	0.00%
Expected term (in years)	6 years	6 years
Risk-free rate	0.51%	1.21%
2014 Omnibus Performance Award Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	76.00%	52.00%
Dividend yield	0.00%	0.00%
Expected term (in years)	6 years	6 years
Risk-free rate	0.51%	1.21%

Stock Incentive Plans - Schedul

Stock Incentive Plans - Schedule of Stock Options and Stock Awards (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 29, 2019
Number of Shares
Outstanding at end of period (in shares)	661,480
Aggregate Intrinsic Value
Share price (in dollars per share)	$ 3.19	$ 4.01
The Plan and the 2014 Plan
Number of Shares
Outstanding at beginning of period (in shares)	676,480
Granted (in shares)	80,000
Exercised (in shares)	0
Forfeited or expired (in shares)	95,000
Outstanding at end of period (in shares)	661,480	676,480
Vested and exercisable (in shares)	296,480
Weighted Average Exercise Price
Outstanding at beginning of period (in dollars per share)	$ 5.48
Granted (in dollars per share)	2.72
Exercised (in dollars per share)	0
Forfeited (in dollars per share)	6.91
Outstanding at end of period (in dollars per share)	4.94	$ 5.48
Vested and exercisable (in dollars per share)	$ 7.43
Weighted Average Remaining Contractual Term (in years)
Outstanding weighted average remaining contractual term	7 years 3 months 18 days	7 years 1 month 6 days
Granted	9 years 8 months 12 days
Exercised	0 years
Forfeited or expired	0 years
Vested and exercisable	4 years 7 months 6 days
Aggregate Intrinsic Value
Outstanding at December 29, 2019 (in shares)		471,000
Outstanding at June 30, 2020	$ 0
Vested and exercisable at June 30, 2020	$ 0
Forfeited or expired (in shares)	95,000
The Plan and the 2014 Plan | CFO
Number of Shares
Forfeited or expired (in shares)	65,000
Aggregate Intrinsic Value
Forfeited or expired (in shares)	65,000

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Income tax (benefit)	$ (1,058)	$ (389)	$ (1,659)	$ (346)
Actual effective rate	19.70%		20.00%
Statutory rate	21.00%		21.00%

Leases - Additional Information

Leases - Additional Information (Details)	Jun. 30, 2020
Minimum
Lessee, Lease, Description [Line Items]
Renewal term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Renewal term	5 years

Leases - Balance Sheet Informat

Leases - Balance Sheet Information (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 29, 2019
Leases [Abstract]
Operating leases	$ 10,965	$ 0
Operating lease, liability, current	2,815
Operating lease, liability, non-current	9,076
Total lease liabilities	$ 11,891
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	us-gaap:OtherLiabilitiesCurrent
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other liabilities

Leases - Lease Cost (Details)

Leases - Lease Cost (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2020USD ($)
Leases [Abstract]
Lease cost	$ 1,605

Leases - Schedule of Lease Liab

Leases - Schedule of Lease Liabilities Maturity (Details) $ in Thousands	Jun. 30, 2020USD ($)
Leases [Abstract]
2020 (remainder)	$ 1,516
2021	2,838
2022	1,979
2023	1,203
2024	1,116
Thereafter	6,458
Total lease payments	15,110
Less: interest	3,220
Present value of lease payments	$ 11,891

Leases - Weighted-Average Lease

Leases - Weighted-Average Lease Information (Details)	Jun. 30, 2020
Leases [Abstract]
Weighted average remaining lease term (years)	7 years 4 months 24 days
Weighted average discount rate	6.40%

Leases - Cash Outflow Informati

Leases - Cash Outflow Information (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2020USD ($)
Leases [Abstract]
Operating cash outflows from operating leases	$ 1,602

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Defined Benefit Plan Disclosure [Line Items]
Employer contribution amount	$ 100	$ 100	$ 200	$ 300
Defined contribution plan, initial contribution
Defined Benefit Plan Disclosure [Line Items]
Employer matching contribution, percent			100.00%
Employer matching contribution, percent of employees gross pay			3.00%
Defined contribution plan, additional contribution
Defined Benefit Plan Disclosure [Line Items]
Employer matching contribution, percent			50.00%
Employer matching contribution, percent of employees gross pay			2.00%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ / shares in Units, $ in Thousands	Feb. 25, 2020	Jun. 11, 2019	Mar. 18, 2013	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
2014 Omnibus Performance Award Plan
Related Party Transaction [Line Items]
Granted (in shares)		30,000
Granted (in dollars per share)	$ 3.32	$ 2.93
Affiliated Entity | Management Agreement
Related Party Transaction [Line Items]
Annual management fees			$ 300
Expenses from management contract				$ 100	$ 100	$ 100	$ 100
Management agreement, term			5 years
Additional renewal period term			1 year
Equity ownership needed to terminate agreement			50.00%

Earnings Per Share - Numerator

Earnings Per Share - Numerator and Denominator of Basic and Diluted Loss per Share Reconciliation (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019
Numerator:
Net (loss)	$ (4,322)	$ (2,302)	$ (7,624)	$ (189)	$ (6,624)	$ (7,812)
Denominator:
Basic weighted average shares outstanding (in shares)	9,779,147		9,779,147		9,779,147	9,779,147
Dilutive effect of stock-based awards (in shares)	0		0		0	0
Diluted weighted average shares outstanding (in shares)	9,779,147		9,779,147		9,779,147	9,779,147
Earnings Per Share, Basic and Diluted [Abstract]
Basic loss per share (in dollars per share)	$ (0.44)		$ (0.78)		$ (0.68)	$ (0.80)
Diluted loss per share (in dollars per share)	$ (0.44)		$ (0.78)		$ (0.68)	$ (0.80)

Earnings Per Share - Anti-Dilut

Earnings Per Share - Anti-Dilutive Common Stock Equivalents Summary (Details) - $ / shares	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of options (in shares)	661,480	593,680
Exercise price of options lower limit (in dollars per share)	$ 2.36	$ 7.65
Exercise price of options upper limit (in dollars per share)	$ 12.58	$ 12.58
Warrants (in shares)	142,185	142,185
Exercise price of warrants lower limit (in dollars per share)	$ 3.33	$ 3.33
Exercise price of warrants upper limit (in dollars per share)	$ 11.88	$ 11.88
Warrants for Underwriters
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of EPS (in shares)	141,000	141,000

Restatement - Balance Sheet Res

Restatement - Balance Sheet Restatement Adjustments (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020	Dec. 29, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 30, 2018
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cash and cash equivalents	$ 4,098		$ 650
Inventory, net	14,810		13,047
Prepaid expenses and other	3,574		2,108
Total current assets	39,556		42,558
Property, plant, and equipment, net	22,779		23,415
Deferred tax asset	1,219		679
Total assets	107,536		101,668
Accrued compensation	1,144		1,225
Other accrued liabilities	4,543		1,979
Total current liabilities	16,318		15,375
Total liabilities	74,645		62,208
Accumulated deficit	(13,185)	$ (8,863)	(6,561)
Total stockholders’ equity	32,891	37,181	39,460	$ 40,684	$ 48,243	$ 48,888
Total liabilities and stockholders’ equity	107,536		$ 101,668
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cash and cash equivalents	4,737
Inventory, net	15,137
Prepaid expenses and other	3,654
Total current assets	40,602
Property, plant, and equipment, net	22,815
Deferred tax asset	926
Total assets	108,325
Accrued compensation	993
Other accrued liabilities	4,312
Total current liabilities	15,936
Total liabilities	74,263
Accumulated deficit	(12,014)	(7,697)
Total stockholders’ equity	34,062	38,347
Total liabilities and stockholders’ equity	108,325
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cash and cash equivalents	(639)
Inventory, net	(327)
Prepaid expenses and other	(80)
Total current assets	(1,046)
Property, plant, and equipment, net	(36)
Deferred tax asset	293
Total assets	(789)
Accrued compensation	151
Other accrued liabilities	231
Total current liabilities	382
Total liabilities	382
Accumulated deficit	(1,171)	(1,166)
Total stockholders’ equity	(1,171)	$ (1,166)
Total liabilities and stockholders’ equity	$ (789)

Restatement - Statement of Oper

Restatement - Statement of Operations Restatement Adjustments (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales	$ 14,975		$ 38,889		$ 49,636	$ 78,356
Cost of sales	13,134		30,677		42,204	61,844
Gross profit	1,841		8,212		7,432	16,512
Selling, general, and administrative expenses	6,343		7,424		12,227	14,696
Operating loss	(4,775)		(6,706)		(5,988)	(5,769)
(Loss) before income tax (benefit)	(5,380)		(8,013)		(8,283)	(8,158)
Income tax (benefit)	(1,058)		(389)		(1,659)	(346)
Net loss	$ (4,322)	$ (2,302)	$ (7,624)	$ (189)	$ (6,624)	$ (7,812)
Net loss per share:
Basic (in dollars per share)	$ (0.44)		$ (0.78)		$ (0.68)	$ (0.80)
Diluted (in dollars per share)	$ (0.44)		$ (0.78)		$ (0.68)	$ (0.80)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales	$ 14,759				$ 49,736
Cost of sales	13,019				40,921
Gross profit	1,740				8,815
Selling, general, and administrative expenses	6,281				12,146
Operating loss	(4,814)				(4,524)
(Loss) before income tax (benefit)	(5,420)				(6,819)
Income tax (benefit)	(1,103)				(1,366)
Net loss	$ (4,317)	(1,137)			$ (5,453)
Net loss per share:
Basic (in dollars per share)	$ (0.44)				$ (0.56)
Diluted (in dollars per share)	$ (0.44)				$ (0.56)
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales	$ 216				$ (100)
Cost of sales	115				1,283
Gross profit	101				(1,383)
Selling, general, and administrative expenses	62				81
Operating loss	39				(1,464)
(Loss) before income tax (benefit)	40				(1,464)
Income tax (benefit)	45				(293)
Net loss	$ (5)	$ (1,165)			$ (1,171)
Net loss per share:
Basic (in dollars per share)	$ 0				$ (0.12)
Diluted (in dollars per share)	$ 0				$ (0.12)

Restatement - Statement of Stoc

Restatement - Statement of Stockholders Equity Restatement Adjustments (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 29, 2019	Dec. 30, 2018
Accumulated deficit:
Net loss	$ (4,322)	$ (2,302)	$ (7,624)	$ (189)	$ (6,624)	$ (7,812)
Accumulated deficit	(13,185)	(8,863)			(13,185)		$ (6,561)
Total stockholders’ equity	32,891	37,181	$ 40,684	$ 48,243	32,891	$ 40,684	$ 39,460	$ 48,888
As Previously Reported
Accumulated deficit:
Net loss	(4,317)	(1,137)			(5,453)
Accumulated deficit	(12,014)	(7,697)			(12,014)
Total stockholders’ equity	34,062	38,347			34,062
Adjustments
Accumulated deficit:
Net loss	(5)	(1,165)			(1,171)
Accumulated deficit	(1,171)	(1,166)			(1,171)
Total stockholders’ equity	$ (1,171)	$ (1,166)			$ (1,171)

Restatement - Statement of Cash

Restatement - Statement of Cash Flows Restatement Adjustment (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019
Cash Flows from Operating Activities:
Net loss	$ (4,322)	$ (2,302)	$ (7,624)	$ (189)	$ (6,624)	$ (7,812)
Deferred income taxes					(1,864)	(728)
Inventory					(1,694)	1,064
Prepaid expenses and other assets					(1,809)	(97)
Accrued and other liabilities					(601)	(956)
Net cash provided by operating activities					693	5,084
Cash Flows from Investing Activities:
Capital expenditures					(760)	(1,880)
Net cash provided by (used in) investing activities					124	(1,839)
Cash and cash equivalents:
Net increase (decrease) in cash and cash equivalents					3,448	(355)
Cash and cash equivalents at end of period	4,098		$ 1,055		4,098	$ 1,055
As Previously Reported
Cash Flows from Operating Activities:
Net loss	(4,317)	(1,137)			(5,453)
Deferred income taxes					(1,571)
Inventory					(2,021)
Prepaid expenses and other assets					(1,889)
Accrued and other liabilities					(983)
Net cash provided by operating activities					1,368
Cash Flows from Investing Activities:
Capital expenditures					(796)
Net cash provided by (used in) investing activities					88
Cash and cash equivalents:
Net increase (decrease) in cash and cash equivalents					4,087
Cash and cash equivalents at end of period	4,737				4,737
Adjustments
Cash Flows from Operating Activities:
Net loss	(5)	$ (1,165)			(1,171)
Deferred income taxes					(293)
Inventory					327
Prepaid expenses and other assets					80
Accrued and other liabilities					382
Net cash provided by operating activities					(675)
Cash Flows from Investing Activities:
Capital expenditures					36
Net cash provided by (used in) investing activities					36
Cash and cash equivalents:
Net increase (decrease) in cash and cash equivalents					(639)
Cash and cash equivalents at end of period	$ (639)				$ (639)